Nontraumatic intracranial haemmorrhage

I9_INTRACRA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints I9_SAH I9_ICH	11015
6. Filter based on genotype QC (FinnGen only)	9679

Control definitions (FinnGen only)

Control exclude: I9_CEREBVASC

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF2

NAME	I9_INTRACRA
CONTROL_EXCLUDE	I9_CEREBVASC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	I9_SAH\|I9_ICH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Nontraumatic intracranial haemmorrhage based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	120107	57004	60805
Only index persons	69638	34146	35492
Unadjusted period prevalence (%)
Whole population	1.68	1.63	1.70
Only index persons	1.31	1.26	1.35
Median age at first event (years)
Whole population	66.34	69.20	63.72
Only index persons	66.62	69.27	64.07

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9679	4384	5295
Unadjusted period prevalence (%)	2.03	1.56	2.43
Median age at first event (years)	65.73	63.75	67.37

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9966: Matched controls
99625

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

+∞

317.3

303

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

278.4

307.7

271

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

+∞

307.7

998

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

11408.9

307.7

2590

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

10.5

307.7

535

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

307.7

3171

14080

N03AB02

ATC

phenytoin; systemic

14.0

307.7

411

306

PA2AD

NOMESCO Finland

CT angiography of brain

45.8

307.7

472

108

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

185.2

307.7

674

G91.0

ICD-10 Finland

Communicating hydrocephalus

24.1

307.7

281

120

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.1

307.7

2843

11353

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

+∞

307.7

646

K91

ICPC

Cerebrovascular disease

31.0

307.7

476

161

N03AF02

ATC

oxcarbazepine; oral

6.6

307.7

593

953

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

7.1

307.7

1023

1580

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

48.4

307.7

856

193

XA800

NOMESCO Finland

Neuropsychological investigation

9.7

307.7

850

952

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

5.7

307.7

628

1154

AA1AD

NOMESCO Finland

CT of head and brain

5.7

307.7

5647

18690

2161

FHL

Neck ligation, big brain

+∞

307.7

403

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

10.1

307.7

536

558

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

2131.7

307.7

2542

N03AX14

ATC

levetiracetam; systemic

10.9

307.7

830

826

N18

ICPC

Paralysis/weakness

14.6

307.7

574

415

AA5PD

NOMESCO Finland

CT examination of brain pefusion

35.5

307.7

239

K90

ICPC

Stroke/cerebrovascular accident

46.1

307.7

1035

250

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

3336.4

307.7

333

4300A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]

+∞

307.7

458

S06.3

ICD-10 Finland

Focal brain injury

12.2

307.7

461

395

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.9

307.7

1143

3217

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

1005.4

307.7

1743

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

1344.1

307.7

1288

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

7.7

307.7

1261

1847

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

8366.5

307.7

783

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

+∞

307.7

387

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

14.6

307.7

419

299

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

81.5

307.7

1651

242

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

5681.1

307.7

2276

G40.9

ICD-10 Finland

Epilepsy, unspecified

7.0

307.7

721

1099

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

716.1

307.7

413

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

182.0

307.7

599

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

+∞

307.7

950

AAF00

NOMESCO Finland

Ventriculostomy

91.3

307.7

617

R4150

NOMESCO Finland

Neuropsychological rehabilitation

43.4

307.7

221

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

+∞

307.7

476

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

128.3

307.7

1836

175

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

11.8

307.7

530

471

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

+∞

307.7

495

R4120

NOMESCO Finland

Occupational therapy

4.4

307.7

913

2238

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

22.0

307.7

608

294

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

650.6

307.7

611

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

161.3

307.7

267

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

930.3

307.7

774

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

11.3

307.7

427

394

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

4.5

301.2

769

1800

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

1001.1

299.2

292

I63.8

ICD-10 Finland

Other cerebral infarction

137.4

296.7

149

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

115.5

290.1

148

I61.5

ICD-10 Finland

Intracerebral haemorrhage, intraventricular

+∞

282.6

270

H53.4

ICD-10 Finland

Visual field defects

7.8

277.3

391

519

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.4

275.3

738

1792

I61.6

ICD-10 Finland

Intracerebral haemorrhage, multiple localized

905.8

271.0

265

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

38.9

263.2

161

43090

ICD-8 Finland

Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata

+∞

253.1

242

I60.3

ICD-10 Finland

Subarachnoid haemorrhage from posterior communicating artery

+∞

248.9

238

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

5.1

239.5

516

1046

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

+∞

238.4

228

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.2

236.2

1041

3526

R47.0

ICD-10 Finland

Dysphasia and aphasia

13.9

235.5

218

160

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

23.2

233.8

169

I60.6

ICD-10 Finland

Subarachnoid haemorrhage from other intracranial arteries

+∞

231.1

221

I61.3

ICD-10 Finland

Intracerebral haemorrhage in brain stem

+∞

231.1

221

AAL00

NOMESCO Finland

Endovascular occlusion of intracranial aneurysm

+∞

227.9

218

T90.5

ICD-10 Finland

Sequelae of intracranial injury

9.8

227.5

266

279

N03AG01

ATC

valproic acid; systemic, rectal

3.7

220.6

758

2192

N19

ICPC

Speech disorder

9.8

219.2

256

268

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

552.4

219.1

217

R51.80

ICD-10 Finland

Headache

2.5

215.7

1542

6728

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

62.3

211.3

117

PA2MT

NOMESCO Finland

Endovascular closure of very extensive brain aneurysm

+∞

209.0

200

Z2445

NOMESCO Finland

Psychologist

5.4

205.4

417

801

PA6AD

NOMESCO Finland

CT of neck arteries

4.7

204.5

484

1061

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

11.1

202.3

216

199

ZXD05

NOMESCO Finland

Urgent procedure

2.0

202.1

3285

19853

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.9

200.6

1023

3752

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

33.8

199.8

127

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

664.5

198.9

196

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

29.1

198.1

132

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

5.0

192.9

430

896

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

35.0

192.2

121

R4130

NOMESCO Finland

Speech therapy

5.5

190.3

380

719

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

45.3

189.9

112

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

14.0

185.9

171

124

I60.4

ICD-10 Finland

Subarachnoid haemorrhage from basilar artery

+∞

184.9

177

43099

ICD-8 Finland

Subarachnoid haemorrhage, Without mention of hypertension

+∞

182.8

175

AA9CW, ,

NOMESCO Finland

71.4

182.7

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

26.7

180.8

124

4309X

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS NUD]

+∞

177.6

170

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

6.8

176.7

281

425

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

173.6

3743

24521

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

1785.4

173.3

168

I61

ICD-10 Finland

Intracerebral haemorrhage

349.1

171.8

173

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

223.8

170.8

176

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

170.5

1917

10052

C08CA06

ATC

nimodipine; systemic

58.6

166.1

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

15.6

161.5

140

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

+∞

158.7

152

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

11.8

158.1

161

138

G40.10

ICD-10 Finland

Simple partial seizures

11.6

155.0

160

140

ZXD35

NOMESCO Finland

Usual procedure

3.7

153.6

501

1393

N03AX18

ATC

lacosamide; systemic

11.6

153.2

158

138

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

12.1

150.8

151

126

N03AF01

ATC

carbamazepine; oral, rectal

3.0

148.5

686

2369

I61.2

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, unspecified

+∞

145.1

139

PA7BD

NOMESCO Finland

CT angiography of neck and brain

6.8

139.9

222

335

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.2

139.0

386

956

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

9.8

137.8

160

166

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

285.4

137.7

140

WX730

NOMESCO Finland

Conventional respirator

5.1

137.1

292

584

PA2YT

NOMESCO Finland

Cerebral artery PTA with stent

672.2

135.0

133

R1260

NOMESCO Finland

Evaluation of communicative skills

5.7

133.3

251

449

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

9.3

132.1

159

173

WX892

NOMESCO Finland

Monitored bed care

2.5

129.8

918

3937

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

11.5

128.4

133

117

FFM32

NOMESCO Finland

Occlusion or excision of atrial appendage transvenously with a closing device

40.3

125.2

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

217.7

125.0

129

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

18.5

124.5

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

11.8

121.9

124

106

205

Kela drug reimbursment

Chronic hypertension

1.7

120.4

3383

23300

W19

ICD-10 Finland

Unspecified fall

2.2

118.3

1184

5872

4310A

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS CUM HYPERTONIA]

+∞

117.9

113

I68.0*E85.9

ICD-10 Finland

Cerebral amyloid angiopathy

59.5

116.2

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

11.2

115.8

122

110

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

+∞

115.8

111

N28

ICPC

Limited function/disability (N)

4.7

115.5

275

604

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

28.7

115.1

G81.9

ICD-10 Finland

Hemiplegia, unspecified

8.9

114.3

142

161

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

8.2

112.5

149

183

G91.1

ICD-10 Finland

Obstructive hydrocephalus

14.0

112.4

103

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.1

108.6

485

1638

GBB00

NOMESCO Finland

Tracheostomy

5.3

107.9

218

416

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.9

107.8

329

872

G41.9

ICD-10 Finland

Status epilepticus, unspecified

10.0

107.2

122

123

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

101.1

6603

54874

B01AC04

ATC

clopidogrel; oral

1.8

100.0

1764

10578

I62.9

ICD-10 Finland

Intracranial haemorrhage (nontraumatic), unspecified

497.8

99.7

I63

ICD-10 Finland

Cerebral infarction

19.9

97.4

183

Kela drug reimbursment

Lamotrigin and topiramate

8.4

97.1

126

151

G40

ICD-10 Finland

Epilepsy

7.6

95.6

135

179

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

5.6

95.4

183

333

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

94.0

570

2263

WX872

NOMESCO Finland

Intensive care

2.5

90.8

606

2518

4311A

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS HYPERTONIA NON INDICAT]

+∞

90.7

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

308.6

89.9

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

89.0

1689

10312

4373A

ICD-9 Finland

Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured

+∞

88.6

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

3.1

88.6

381

1258

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

19.5

87.7

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

85.7

784

3732

S06.2

ICD-10 Finland

Diffuse brain injury

5.6

85.5

163

295

4319X

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS NUD]

+∞

84.5

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

9.4

84.1

100

107

C08CA01

ATC

amlodipine; oral

1.5

83.6

4162

32020

FFW96

NOMESCO Finland

Other operation on atria

19.2

83.2

AAK00

NOMESCO Finland

Cranioplasty

34.8

82.3

A28

ICPC

Limited function/disability NOS

1.6

82.0

2259

15196

I67.8

ICD-10 Finland

Other specified cerebrovascular diseases

26.8

81.7

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

27.6

81.1

S06.8

ICD-10 Finland

Other intracranial injuries

14.4

80.9

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

79.2

835

4195

B01AA03

ATC

warfarin; systemic

1.6

78.7

2343

16039

N88

ICPC

Epilepsy

8.1

78.3

105

131

I60.5

ICD-10 Finland

Subarachnoid haemorrhage from vertebral artery

+∞

78.2

ZXY02

NOMESCO Finland

Neuropsychologist

11.3

77.6

S06.0

ICD-10 Finland

Concussion

1.9

75.7

1052

5817

N05BA09

ATC

clobazam; oral

9.3

75.6

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

75.6

612

2767

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

10.3

74.6

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

74.5

778

3892

I60

ICD-10 Finland

Subarachnoid haemorrhage

248.5

72.4

R47.1

ICD-10 Finland

Dysarthria and anarthria

5.7

71.0

133

237

M03BX01

ATC

baclofen; systemic

3.9

70.3

210

548

R41.0

ICD-10 Finland

Disorientation, unspecified

2.6

69.2

428

1712

G81.1

ICD-10 Finland

Spastic hemiplegia

26.2

68.0

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

67.8

2989

22174

B01AC07

ATC

dipyridamole; systemic

2.3

67.5

525

2332

G40.89

ICD-10 Finland

Other epilepsy

9.8

66.8

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

64.9

420

1717

S01.0

ICD-10 Finland

Open wound of scalp

1.9

64.8

896

4934

SPAT1229

SPAT

Assessment of need for aid

1.9

64.5

883

4848

S02.11

ICD-10 Finland

Fracture of base of skull, open

8.8

63.7

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

622.0

62.9

XX4AW, ,

NOMESCO Finland

25.4

61.4

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.9

60.3

179

465

WX882

NOMESCO Finland

High dependency care

2.8

59.4

312

1150

N05AH04

ATC

quetiapine; oral

1.6

59.0

1407

9048

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

10.2

59.0

G91.8

ICD-10 Finland

Other hydrocephalus

18.5

57.7

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

57.2

509

2388

SPAT1216

SPAT

Assessment of functional ability

1.6

56.9

1708

11598

R55

ICD-10 Finland

Syncope and collapse

1.7

56.7

1203

7500

N80

ICPC

Head injury other

3.2

56.5

233

750

Z3226

NOMESCO Finland

Physiotherapist

1.6

56.1

1603

10759

R42

ICD-10 Finland

Dizziness and giddiness

1.5

56.0

2235

16130

L28

ICPC

Limited function/disability (L)

1.5

55.4

2069

14725

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

55.4

619

3166

AAF15

NOMESCO Finland

Ventriculoatrial shunt

9.1

55.0

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

5.2

55.0

114

223

I67.2

ICD-10 Finland

Cerebral atherosclerosis

11.5

54.2

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

53.5

1083

6661

AAK80

NOMESCO Finland

Partial excision of skull cap

272.5

53.2

AAC40

NOMESCO Finland

Extirpation of intracranial arterio-venous malformation

184.3

53.0

R4120, ,

SPAT

3.8

52.9

163

435

XCK00

NOMESCO Finland

Perimetry

1.9

52.7

658

3496

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

4.0

52.2

147

368

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

51.7

963

5787

C02AC05

ATC

moxonidine; oral

2.1

51.4

509

2489

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

51.2

1148

7249

I69.4

ICD-10 Finland

Sequelae of stroke, not specified as haemorrhage or infarction

261.9

51.1

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.9

50.0

240

843

M01AH05

ATC

etoricoxib; oral

0.7

49.4

3573

43438

43000

ICD-8 Finland

Subarachnoid haemorrhage, Post aneyrisma sacculare, cum hypertonia

+∞

49.0

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.3

49.0

188

580

YKA02

NOMESCO Finland

Excision of kidneys from cadaver donor

170.8

48.9

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

48.7

764

4364

PA2CG

NOMESCO Finland

Extensive MRI examination of vessels in the head with high intensity magnet

10.2

48.3

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

48.2

1598

11053

Z2446

NOMESCO Finland

Social worker

2.0

48.0

544

2793

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

5.9

48.0

147

R4130, ,

SPAT

7.9

47.6

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

47.5

542

2790

S02.00

ICD-10 Finland

Fracture of the upper part of the head closed

6.9

47.3

107

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

47.3

661

3642

C09AA05

ATC

ramipril; oral

1.4

47.2

2598

19826

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

11.8

47.1

R4110

NOMESCO Finland

Physiotherapy

1.4

46.5

2422

18290

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

46.2

1263

8357

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

+∞

45.9

G46.4*I67.9

ICD-10 Finland

Cerebellar stroke syndrome

160.7

45.8

N05AX08

ATC

risperidone; systemic

1.7

45.7

913

5585

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

449.7

45.3

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

44.9

557

2951

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

+∞

44.8

XA400

NOMESCO Finland

EEG

6.0

44.3

131

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

43.8

1619

11433

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

43.7

2543

19546

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.6

43.5

259

1017

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

43.4

3153

25135

S06.4

ICD-10 Finland

Epidural haemorrhage

10.0

43.3

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

8.5

42.9

R53

ICD-10 Finland

Malaise and fatigue

1.4

42.8

2247

16952

N06AB04

ATC

citalopram; systemic

1.5

42.6

1715

12312

A06AD11

ATC

lactulose; oral

1.5

42.5

1674

11966

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

42.4

1763

23714

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

7.7

41.5

C09AA02

ATC

enalapril; systemic

1.4

40.8

2047

15302

TAB00

NOMESCO Finland

Lumbar puncture

2.3

40.8

332

1502

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

39.8

548

3002

SPAT1234

SPAT

Support of social functional capacity

1.8

39.4

590

3318

N06AB10

ATC

escitalopram; oral

1.5

38.8

1336

9277

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.6

38.6

233

921

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

51.3

38.5

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

38.4

1554

11143

C07AB07

ATC

bisoprolol; oral

1.3

38.3

4948

42679

P20

ICPC

Memory disturbance

1.5

38.2

1619

11716

C07AB02

ATC

metoprolol; systemic

1.4

37.1

2159

16516

G94.2

ICD-10 Finland

Hydrocephalus in other diseases classified elsewhere

130.5

36.7

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

36.6

497

2710

G41.2

ICD-10 Finland

Complex partial status epilepticus

10.9

36.4

N03AX23

ATC

brivaracetam; systemic

10.3

36.0

AA1AA

NOMESCO Finland

Head X-ray examination

3.8

35.9

110

293

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

35.7

275

1216

N29

ICPC

Neurological sympt/complt other

2.7

35.4

197

749

XX2BT

NOMESCO Finland

Other injection with X-ray guidance

9.4

35.3

Z50.5

ICD-10 Finland

Speech therapy

3.6

35.0

116

326

G41.0

ICD-10 Finland

Grand mal status epilepticus

12.1

35.0

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.7

34.9

195

743

Z43.0

ICD-10 Finland

Attention to tracheostomy

12.6

34.9

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

34.8

1519

11031

C10AA01

ATC

simvastatin; oral

1.3

34.8

4273

36418

43098

ICD-8 Finland

Subarachnoid haemorrhage, Alia definita, hypertonia non indicata

+∞

34.4

43190

ICD-8 Finland

Cerebral haemorrhage, Intracerebralis, hypertonia non indicata

+∞

34.4

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

34.2

347

1711

G93.90

ICD-10 Finland

Brain death

175.5

33.7

SPAT1254

SPAT

Administration of medicine

1.4

33.5

1417

10224

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

6.8

33.4

D21

ICPC

Swallowing problem

2.8

33.1

163

582

OAB43, ,

SPAT

0.6

33.0

553

9130

N03AX09

ATC

lamotrigine; oral

2.2

32.9

268

1213

I67.0

ICD-10 Finland

Dissection of cerebral arteries, nonruptured

+∞

32.3

4301A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACH.POST MALFORMAT.ARTERIOVENOSAM]

+∞

32.3

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

5.3

32.2

121

F05.9

ICD-10 Finland

Delirium, unspecified

2.3

31.9

253

1132

Z3231

NOMESCO Finland

Registered nurse

1.3

31.9

2352

18611

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

31.9

549

3216

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

31.8

784

5042

PA7RT

NOMESCO Finland

Medical infusion to cerebral artery

87.8

31.7

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

8.9

31.5

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

31.3

469

2636

WYA20

NOMESCO Finland

Home visit

2.3

30.9

234

1028

3451A

ICD-9 Finland

Epilepsy, Generalised convulsive epilepsy

8.4

30.8

PA2AG

NOMESCO Finland

Restrected MRI examination of vessels in the head with high intensity magnet

10.3

30.6

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

30.6

1340

9718

C08CA02

ATC

felodipine; oral

1.5

30.4

1000

6857

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.2

30.2

192

C08CA05

ATC

nifedipine; systemic

1.7

30.0

627

3871

XX3XW, ,

NOMESCO Finland

4.7

29.8

145

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.9

29.8

141

493

315

Kela drug reimbursment

Clopidogrel

3.6

29.6

271

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

29.4

348

1814

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

29.4

443

2496

43199

ICD-8 Finland

Cerebral haemorrhage, Without mention of hypertension

+∞

29.2

4318X

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS ALIA DEFINITA]

+∞

29.2

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

9.2

29.1

H53.2

ICD-10 Finland

Diplopia

2.1

29.0

274

1317

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

28.9

603

3719

G44.2

ICD-10 Finland

Tension-type headache

1.5

28.9

918

6248

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

10.3

28.9

N06AX11

ATC

mirtazapine; oral

1.3

28.8

2780

22791

YJA10

NOMESCO Finland

Excision of liver from cadaver donor

292.7

28.8

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

7.8

28.5

N05BA01

ATC

diazepam; systemic, rectal

1.5

28.4

1091

7714

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.7

28.4

1279

17178

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.9

28.3

130

447

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

6.2

28.3

P15

ICPC

Chronic alcohol abuse

2.3

28.2

207

897

G942, I602,

ICD-10 Finland

+∞

28.1

43009

ICD-8 Finland

Subarachnoid haemorrhage, NUD, cum hypertonia

+∞

28.1

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

6.5

28.0

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.0

27.7

123

415

I68.0

ICD-10 Finland

Cerebral amyloid angiopathy

100.3

27.6

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.0

27.6

201

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.1

27.6

113

364

S06.9

ICD-10 Finland

Intracranial injury, unspecified

4.0

27.5

193

Z94.0

ICD-10 Finland

Kidney transplant status

3.5

27.2

277

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

27.0

1460

10966

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.7

27.0

140

514

F80.1

ICD-10 Finland

Expressive language disorder

4.0

26.8

192

A98

ICPC

Health maint/preventive medicine

0.8

26.6

7650

80938

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.3

26.6

301

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

6.0

26.3

RS313, ,

NOMESCO Finland

6.0

26.3

3313A

ICD-9 Finland

Other cerebral degenerations, Communicating hydrocephalus

29.3

26.2

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.6

26.2

153

597

F10.24

ICD-10 Finland

Alcohol depence active use

3.0

26.1

117

397

127

Kela drug reimbursment

Transplant complication

2.9

25.8

118

405

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

3.4

25.8

277

G00.9

ICD-10 Finland

Bacterial meningitis, unspecified

6.5

25.5

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

4.7

25.4

124

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

4.6

25.4

128

WX704

NOMESCO Finland

Intubation

1.6

25.3

639

4131

RS221, ,

NOMESCO Finland

2.9

25.2

121

427

SPAT1252

SPAT

Overall medication plan or its review

1.6

25.1

653

4247

I95.1

ICD-10 Finland

Orthostatic hypotension

1.7

25.0

433

2539

R40.2

ICD-10 Finland

Coma, unspecified

3.2

24.9

303

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

24.8

1439

10919

I65.0

ICD-10 Finland

Occlusion and stenosis of vertebral artery

130.3

24.6

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.3

24.5

181

787

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

24.5

1876

14846

W06

ICD-10 Finland

Fall involving bed

3.0

24.0

108

368

YFA50

NOMESCO Finland

Excision of heart for preparation of homograft

+∞

24.0

C03CA01

ATC

furosemide; systemic

1.3

23.9

3500

30038

R51

ICD-10 Finland

Headache

1.8

23.8

334

1840

C09BA02

ATC

enalapril and diuretics; systemic

1.5

23.7

786

5388

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.2

23.7

287

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.2

23.7

152

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.1

23.4

209

983

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

23.3

1005

7248

4019X

ICD-9 Finland

Essential hypertension, Unspecified

1.9

23.2

312

1696

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.2

23.2

296

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

23.0

181

809

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

5.4

23.0

GBB03

NOMESCO Finland

Percutaneous tracheostomy

20.1

22.9

43091

ICD-8 Finland

Subarachnoid haemorrhage, Postaneyrisma arteriovenosum, hypertonia non indicata

+∞

22.9

I62.1

ICD-10 Finland

Nontraumatic extradural haemorrhage

+∞

22.9

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

4.3

22.9

139

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

22.8

1074

14379

2132

FHL

Ventricular operators sunt

30.1

22.7

TK800

NOMESCO Finland

Hemodialysis

2.2

22.5

184

836

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

22.5

465

2861

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

7.5

22.4

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

21.9

184

845

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.5

21.9

142

583

C10AA05

ATC

atorvastatin; oral

1.2

21.9

3768

32829

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

21.9

303

1664

43399

ICD-8 Finland

Cerebral thrombosis, Without mention of hypertension

+∞

21.9

43100

ICD-8 Finland

Cerebral haemorrhage, Intracerebralis, cum hypertonia

+∞

21.9

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

21.7

1003

7319

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.1

21.7

298

PA2HT

NOMESCO Finland

Extensive embolisation of arterio-venous malformation of the brain

220.4

21.6

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

21.5

1997

16186

OAA67, ,

SPAT

0.6

21.4

311

5355

A12BA01

ATC

potassium chloride; oral

1.6

21.4

499

3164

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

21.3

305

1692

K89

ICPC

Transient cerebral ischaemia

3.0

21.2

302

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

21.1

896

6439

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

21.0

348

2016

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.4

21.0

141

589

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

5.0

20.8

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.2

20.5

261

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

3.2

20.3

258

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.0

20.2

209

1040

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.1

20.1

264

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

19.8

405

2484

PA2JT

NOMESCO Finland

Very extensive embolisation of arterio-venous malformation of the brain

35.8

19.8

WW806

NOMESCO Finland

Transfer from treating institution to lower-Level care, accompanied by doctor

73.6

19.7

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

19.6

992

7348

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

19.6

2338

19508

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

19.5

1081

8123

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

2.9

19.5

306

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.9

19.3

308

A04

ICPC

Weakness/tiredness general

1.3

19.1

1306

10130

WW804

NOMESCO Finland

Transfer from treating institution to higher-Level care, accompanied by doctor

7.5

19.1

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.5

19.1

121

493

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.7

18.9

100

373

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

6.3

18.8

A41.9

ICD-10 Finland

Sepsis, unspecified

1.7

18.8

348

2082

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.3

18.7

133

571

C03AA03

ATC

hydrochlorothiazide; oral

1.4

18.6

854

6218

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.9

18.6

228

1205

A10AB05

ATC

insulin aspart; parenteral

1.5

18.4

596

4063

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

18.4

599

4088

C08CA13

ATC

lercanidipine; oral

1.3

18.4

1320

10307

L01AX03

ATC

temozolomide; systemic

3.3

18.3

212

E85.4

ICD-10 Finland

Organ-limited amyloidosis

5.8

18.3

S00.0

ICD-10 Finland

Superficial injury of scalp

1.9

18.3

216

1127

EB4VA, ,

NOMESCO Finland

0.7

18.3

507

7499

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

18.0

587

4009

L04AA06

ATC

mycophenolic acid; systemic

2.3

18.0

133

581

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

18.0

320

1894

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.1

17.9

171

827

A29

ICPC

General symptom/complaint other

1.3

17.9

1162

8943

M01AE01

ATC

ibuprofen; systemic, rectal

0.8

17.9

6760

71733

C08DB01

ATC

diltiazem; oral

1.5

17.9

554

3745

4308X

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS ALIA DEFINITA]

+∞

17.7

N05BA04

ATC

oxazepam; oral

1.3

17.4

2114

17631

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.8

17.4

137

G03.9

ICD-10 Finland

Meningitis, unspecified

5.1

17.4

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

2.5

17.2

104

415

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.9

17.1

198

1027

NK6AI

NOMESCO Finland

Other cone beam scan

17.4

16.9

7803A

ICD-9 Finland

General symptoms, Convulsions

3.2

16.9

213

-, ,

ICD-10 Finland

1.9

16.8

204

1076

Y86

ICD-10 Finland

Sequelae of other accidents

3.8

16.7

132

OAA80, ,

SPAT

0.5

16.7

134

2772

4341A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral embolism

+∞

16.7

R01AD12

ATC

fluticasone furoate; nasal

0.8

16.6

1276

15994

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.5

16.6

156

N30.0

ICD-10 Finland

Acute cystitis

1.3

16.6

1337

10602

SPAT1301

SPAT

No procedures

1.2

16.5

2655

22802

PA7KT

NOMESCO Finland

Temporary closure of brain artery

170.2

16.5

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

16.4

848

6300

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

4.6

16.3

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

16.2

884

6620

S02.30

ICD-10 Finland

Fracture of orbital floor, closed

2.8

16.2

272

F05.8

ICD-10 Finland

Other delirium

2.7

16.1

311

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

3.4

16.1

169

N05CF01

ATC

zopiclone; oral

1.2

16.1

2870

24895

N01

ICPC

Headache

1.5

16.0

577

4018

ZXD00

NOMESCO Finland

Emergency procedure

1.8

16.0

243

1375

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

15.9

1074

8304

U04

ICPC

Incontinence urine

1.5

15.9

540

3717

2BD01, ,

NOMESCO Finland

4.9

15.9

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.6

15.8

412

2682

F01.8

ICD-10 Finland

Other vascular dementia

6.4

15.8

RP120, ,

NOMESCO Finland

33.4

15.7

4331X

ICD-9 Finland

Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS SINE INFARCTU CEREBR]

+∞

15.6

PA2GT

NOMESCO Finland

Embolisation of arterio-venous malformation of the brain

85.2

15.6

742, ,

NOMESCO Finland

5.1

15.5

A86

ICD-10 Finland

Unspecified viral encephalitis

3.9

15.4

117

H43.1

ICD-10 Finland

Vitreous haemorrhage

1.9

15.3

202

1095

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

15.3

377

2425

N03AE01

ATC

clonazepam; systemic

1.5

15.3

412

2704

S42.0

ICD-10 Finland

Fracture of clavicle

1.8

15.2

205

1119

E87.6

ICD-10 Finland

Hypokalaemia

1.7

15.2

295

1788

JN5BD

NOMESCO Finland

Head and body CT examination for trauma

2.7

15.2

287

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

3.4

15.1

156

G41.8

ICD-10 Finland

Other status epilepticus

13.0

15.1

TJD20

NOMESCO Finland

Change of gastrostomy tube

3.9

15.1

110

74789

ICD-8 Finland

Other congenital anomalies of circulatory system, Other specified anomalies of circulatory system

45.0

15.0

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

1.9

15.0

196

1059

3A064, ,

NOMESCO Finland

4.0

15.0

106

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

2.8

15.0

256

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

14.9

4254

38436

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.3

14.9

106

456

R50.9

ICD-10 Finland

Fever, unspecified

1.3

14.9

1173

9263

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

6.5

14.9

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

6.8

14.8

G30.8

ICD-10 Finland

Other Alzheimer disease

1.7

14.8

281

1693

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

14.7

2368

20294

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

3.1

14.7

194

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

4.1

14.7

I63.6

ICD-10 Finland

Cerebral infarction due to cerebral venous thrombosis, nonpyogenic

+∞

14.6

4331A

ICD-9 Finland

Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS CUM INFARCTU CEREBRI]

+∞

14.6

43300

ICD-8 Finland

Cerebral thrombosis, Wtih hypertension (benign)

+∞

14.6

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

14.5

1586

13043

R11

ICD-10 Finland

Nausea and vomiting

1.4

14.5

655

4756

I65.1

ICD-10 Finland

Occlusion and stenosis of basilar artery

150.2

14.5

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

1.7

14.4

259

1538

V03AE02

ATC

sevelamer; oral

3.3

14.4

156

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

2.9

14.4

234

L15

ICPC

Knee symptom/complaint

0.8

14.3

1325

16252

RS340, ,

NOMESCO Finland

4.9

14.2

W17

ICD-10 Finland

Other fall from one level to another

1.6

14.2

298

1843

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

14.2

322

2030

R1250

NOMESCO Finland

Evaluation of functional capability

1.8

14.2

194

1064

3AX01, ,

NOMESCO Finland

4.6

14.2

Z03

ICPC

Housing/neighbourhood problem

2.9

14.1

215

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

5.7

14.1

SPAT1251

SPAT

Organisation of medication

1.6

14.1

301

1871

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

14.1

2118

24666

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

14.0

478

3294

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.7

14.0

811

10589

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

4.9

14.0

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

4.3

14.0

A11CC03

ATC

alfacalcidol; systemic

1.8

13.9

196

1085

J01EA01

ATC

trimethoprim; systemic

1.2

13.9

2103

17900

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.2

13.9

112

509

N03AX16

ATC

[U] pregabalin

1.2

13.9

1762

14727

G93.6

ICD-10 Finland

Cerebral oedema

30.0

13.9

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

2.6

13.8

285

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.0

13.6

147

746

I72.0

ICD-10 Finland

Aneurysm and dissection of carotid artery

5.1

13.6

43198

ICD-8 Finland

Cerebral haemorrhage, Aliandefinita, hypertonia non indicata

+∞

13.5

43008

ICD-8 Finland

Subarachnoid haemorrhage, Alii definiti, cum hypertonia

+∞

13.5

SPAT1276

SPAT

Outlining of treatment with patient or their family members

1.8

13.5

195

1088

N02BE01

ATC

paracetamol; systemic, rectal

1.2

13.5

8001

76643

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

4.8

13.5

F03

ICD-10 Finland

Unspecified dementia

1.4

13.5

501

3511

K78

ICPC

Atrial fibrillation/flutter

1.4

13.5

757

5695

AAK85

NOMESCO Finland

Replantation of previously excised part of skull cap

140.1

13.4

B01AB05

ATC

enoxaparin; parenteral

1.2

13.4

2619

22829

N02AA05

ATC

oxycodone; systemic

1.2

13.4

1772

14873

L82

ICD-10 Finland

Seborrhoeic keratosis

0.8

13.3

1001

12615

SPAT1042

SPAT

Guidance concerning balance maintenance

3.0

13.3

185

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

2.8

13.1

224

RT152, ,

NOMESCO Finland

40.1

13.1

RS230, ,

NOMESCO Finland

3.4

13.1

131

F01

ICD-10 Finland

Vascular dementia

3.4

13.1

136

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

13.1

327

2111

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

13.1

824

6305

R33

ICD-10 Finland

Retention of urine

1.3

13.0

798

6080

WW200, ,

SPAT

0.8

13.0

1710

20220

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

5.4

13.0

Z51.5

ICD-10 Finland

Palliative care

1.3

13.0

874

6753

G81

ICD-10 Finland

Hemiplegia

28.4

12.9

A12AA04

ATC

calcium carbonate; oral

2.0

12.9

129

637

A10AE04

ATC

insulin glargine; parenteral

1.4

12.9

741

5591

EB1VA, ,

NOMESCO Finland

0.7

12.9

714

9384

S22.3

ICD-10 Finland

Fracture of rib

1.4

12.9

570

4124

4351A

ICD-9 Finland

Transient cerebral ischaemia, Vertebral artery syndrome

4.2

12.9

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

4.3

12.8

L57.0

ICD-10 Finland

Actinic keratosis

0.7

12.8

655

8715

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.3

12.7

760

5770

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

3.0

12.6

180

Y94.0

ICD-10 Finland

Accident at home

1.9

12.6

160

859

2127

FHL

Ventriculostomy

69.9

12.6

AA9PW, ,

NOMESCO Finland

32.0

12.6

S09.9

ICD-10 Finland

Unspecified injury of head

2.0

12.5

126

624

G942, I615,

ICD-10 Finland

+∞

12.5

2164

FHL

Crotigree

+∞

12.5

4349A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral artery occlusion, unspecified[OCCL/STENOS ARTER.CEREBRALES NUD CUM INFARCTU CEREB]

+∞

12.5

4360A

ICD-9 Finland

Acute but ill-defined cerebrovascular disease[MORBUS CEREBROVASCULARIS ACUTUS NON DEFINITUS]

+∞

12.5

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

12.5

459

3212

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

12.3

676

5064

N30.9

ICD-10 Finland

Cystitis, unspecified

1.4

12.3

514

3683

H3603, E103,

ICD-10 Finland

2.9

12.3

194

2152

FHL

Extraction, big brain

5.3

12.3

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.1

12.3

111

529

R01AD58

ATC

fluticasone, combinations; nasal

0.8

12.2

918

11579

Z72.1

ICD-10 Finland

Alcohol use

2.4

12.2

339

G44.8

ICD-10 Finland

Other specified headache syndromes

2.5

12.2

309

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.4

12.2

588

4318

XX3DW

NOMESCO Finland

Time consuming IT work

1.3

12.1

812

6267

S72.0

ICD-10 Finland

Fracture of neck of femur

1.5

11.9

426

2965

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

11.9

373

2530

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

1.8

11.9

177

999

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

4.4

11.9

R13

ICD-10 Finland

Dysphagia

1.4

11.9

538

3909

SPAT1244

SPAT

Occupational therapy

2.3

11.8

369

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.4

11.8

464

3288

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

3.9

11.8

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

11.8

600

4445

X58

ICD-10 Finland

Exposure to other specified factors

1.3

11.7

954

7557

Z98.2

ICD-10 Finland

Presence of cerebrospinal fluid drainage device

10.5

11.7

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

3.0

11.7

167

3459X

ICD-9 Finland

Epilepsy, unspecified

4.2

11.7

SPAT1240

SPAT

Therapeutic discussion

1.4

11.7

494

3548

S82

ICPC

Naevus/mole

0.7

11.6

606

8042

OAB48, ,

SPAT

0.7

11.6

330

4863

I66.9

ICD-10 Finland

Occlusion and stenosis of unspecified cerebral artery

65.0

11.6

I65.9

ICD-10 Finland

Occlusion and stenosis of unspecified precerebral artery

65.0

11.6

J01DA01

ATC

[U] cefalexin

1.2

11.6

5069

47012

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

5.2

11.5

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

2.6

11.5

235

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.2

11.5

G942, I601,

ICD-10 Finland

+∞

11.5

I66.0

ICD-10 Finland

Occlusion and stenosis of middle cerebral artery

+∞

11.5

I67.5

ICD-10 Finland

Moyamoya disease

+∞

11.5

N03AX15

ATC

zonisamide; oral

5.7

11.5

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

2.6

11.4

259

N05CD08

ATC

midazolam; nasal, systemic

1.7

11.4

188

1093

ZXA00

NOMESCO Finland

Right side

1.2

11.4

2224

19342

N99

ICPC

Neurological disease other

2.1

11.3

100

473

R41.3

ICD-10 Finland

Other amnesia

1.6

11.3

251

1578

C09CA01

ATC

losartan; oral

1.2

11.3

2211

19234

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.5

11.3

326

2176

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

3.9

11.2

G72.8

ICD-10 Finland

Other specified myopathies

1.9

11.2

143

770

RS222, ,

NOMESCO Finland

2.2

11.2

429

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

4.6

11.1

F01.39

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without information on additional symptoms

5.5

11.1

RS314, ,

NOMESCO Finland

5.5

11.1

ZXC95

NOMESCO Finland

Use of surgical navigator

2.2

11.1

385

C02EA02, ,

ATC

1.4

11.0

416

2926

L04AD02

ATC

tacrolimus; systemic

2.6

11.0

229

G91.3

ICD-10 Finland

Post-traumatic hydrocephalus, unspecified

10.0

11.0

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

10.9

2189

19069

AA1XD

NOMESCO Finland

Other special CT of head and brain

3.4

10.9

112

E86

ICD-10 Finland

Volume depletion

1.6

10.9

234

1459

2102

FHL

Exploratory craniotomy and / or cranectomy

43.3

10.9

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.8

10.9

1363

16232

J01CF02

ATC

cloxacillin; systemic

1.7

10.9

181

1056

HA1RA, ,

SPAT

0.4

10.9

1549

TGB20

NOMESCO Finland

Tracheostomy tube replacement

10.5

10.7

N05CD07

ATC

temazepam; oral

1.3

10.7

1075

8736

N07

ICPC

Convulsion/seizure

4.4

10.7

C02DE04, ,

ATC

1.6

10.7

263

1694

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.2

10.7

1150

9420

APM

Auricle closure

21.5

10.7

GD1AA, ,

SPAT

0.7

10.6

547

7275

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.8

10.6

1333

15876

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

1.8

10.6

145

798

7478X

ICD-9 Finland

Other congenital anomalies of circulatory system, Other specified anomalies of circulatory system

60.0

10.6

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.8

10.6

2363

26711

SPAT1053

SPAT

Memory test

1.2

10.6

1428

11982

-2, ,

ICPC

2.6

10.6

222

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

2.8

10.5

183

K03.64

ICD-10 Finland

Dental calculus supragingival

0.8

10.5

1465

17269

N07BB01

ATC

disulfiram; oral

1.6

10.5

220

1364

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

10.5

2318

20352

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.7

10.5

610

7968

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

10.5

274

1790

ZX114

NOMESCO Finland

Intramuscular

2.2

10.5

402

T74.1

ICD-10 Finland

Physical abuse

2.3

10.5

332

RS220, ,

NOMESCO Finland

2.2

10.4

383

AAC20

NOMESCO Finland

Anastomosis to intracranial vessel

+∞

10.4

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.5

10.4

274

1793

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

10.4

1027

8332

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.6

10.4

251

3819

34400

ICD-8 Finland

Other cerebral paralysis, Hemiplegia NUD

7.7

10.3

G81.0

ICD-10 Finland

Flaccid hemiplegia

16.0

10.3

PA5AC

NOMESCO Finland

Angiography of arteries to the face with X-ray

32.5

10.3

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.8

10.3

1254

14983

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

10.3

434

3118

RS122, ,

NOMESCO Finland

4.9

10.2

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

23.4

10.2

E85.9

ICD-10 Finland

Amyloidosis, unspecified

3.8

10.2

WW805

NOMESCO Finland

Transfer from treating institution to lower-Level care, accompanied by paramedic/nurse

13.1

10.1

Z50.1

ICD-10 Finland

Other physical therapy

1.4

10.1

379

2667

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

2.6

10.0

211

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

2.9

10.0

150

RF420, ,

NOMESCO Finland

2.1

10.0

450

Z01.2

ICD-10 Finland

Dental examination

0.9

9.9

2522

28246

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.6

9.9

224

1418

RF120, ,

NOMESCO Finland

2.2

9.8

373

PA7CC

NOMESCO Finland

Very extensive angiography of arteries of neck and brain

12.2

9.8

S02.70

ICD-10 Finland

Multiple fractures involving skull and facial bones, closed

3.3

9.8

105

R518, ,

ICD-10 Finland

4.2

9.8

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

2.4

9.8

279

G46.7*I67.9

ICD-10 Finland

Other lacunar syndromes

26.0

9.8

RT151, ,

NOMESCO Finland

26.0

9.8

F01.1

ICD-10 Finland

Multi-infarct dementia

4.9

9.8

S12.2

ICD-10 Finland

Fracture of other specified cervical vertebra

2.2

9.8

368

OAB95, ,

SPAT

0.5

9.8

105

1964

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

4.5

9.7

PA6AM

NOMESCO Finland

Simple MRI examination of neck vasculature with 3 Tesla magnet

9.5

9.7

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.4

9.7

418

3012

P16

ICPC

Acute alcohol abuse

2.1

9.7

441

79199

ICD-8 Finland

Headache

2.0

9.7

104

530

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

7.3

9.7

G93.4

ICD-10 Finland

Encephalopathy, unspecified

3.8

9.6

K91

ICD-10 Finland

Postprocedural disorders of digestive system, not elsewhere classified

55.0

9.6

I65.3

ICD-10 Finland

Occlusion and stenosis of multiple and bilateral precerebral arteries

55.0

9.6

F21, ,

ICPC

2.1

9.6

383

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.0

9.6

456

C02CA01

ATC

prazosin; oral

1.7

9.6

152

876

C07AG02

ATC

carvedilol; oral

1.4

9.6

502

3737

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

2.7

9.6

187

S02.10

ICD-10 Finland

Fracture of base of skull, closed

3.1

9.6

122

D68.8

ICD-10 Finland

Other specified coagulation defects

2.4

9.6

264

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.7

9.5

474

6337

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.5

9.5

285

1918

7804A

ICD-9 Finland

General symptoms, Dizziness and giddiness

1.9

9.5

112

589

W18

ICD-10 Finland

Other fall on same level

2.6

9.5

211

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.9

9.5

2404

26949

L89

ICD-10 Finland

Decubitus ulcer and pressure area

1.7

9.5

173

1037

196

Kela drug reimbursment

Paricalcitol and cinacalcet

3.1

9.5

128

2213

FHL

Hematoma removal, intracerebral or cerebral palsy reversion

100.1

9.4

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

1.7

9.4

162

956

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

9.4

1333

11234

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

3.7

9.4

G942, I690,

ICD-10 Finland

+∞

9.4

G942, I609,

ICD-10 Finland

+∞

9.4

S72.1

ICD-10 Finland

Pertrochanteric fracture

1.6

9.4

233

1507

R01AD59

ATC

mometasone, combinations; nasal

0.6

9.3

121

2143

5541

FHL

Subclavia and / or carotid endarterectomy, reconstruction or bypass surgery

12.3

9.3

AAF10

NOMESCO Finland

Lumboperitoneal shunt

21.7

9.3

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

9.3

185

1134

SPAT1101

SPAT

Orthostatic test

1.4

9.3

400

2884

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

6.9

9.3

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

8.6

9.3

Z08

ICPC

Social welfare problem

2.1

9.2

404

6350C

ICD-9 Finland

Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]

1.7

9.2

167

1001

PA2DG

NOMESCO Finland

Very extensive MRI examination of vessels in the head with high intensity magnet

13.6

9.2

RT132, ,

NOMESCO Finland

13.6

9.2

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.4

9.1

339

2380

V03AE03

ATC

lanthanum carbonate; oral

3.4

9.1

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

1.8

9.1

121

662

RL130, ,

NOMESCO Finland

4.3

9.1

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.2

9.1

1403

11918

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.6

9.1

206

1305

RS130, ,

NOMESCO Finland

4.8

9.0

H47.2

ICD-10 Finland

Optic atrophy

3.1

9.0

116

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.2

9.0

341

V03AA01, ,

ATC

2.0

9.0

509

R5110, ,

SPAT

1.3

9.0

692

5445

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.5

9.0

229

1491

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.6

9.0

207

1317

M05BA04

ATC

alendronic acid; oral

1.3

9.0

768

6124

L76

ICPC

Fracture: other

1.5

8.9

245

1620

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

1.8

8.9

124

688

A69.2

ICD-10 Finland

Lyme disease

0.6

8.9

210

3209

A10AC01

ATC

insulin (human); parenteral

1.3

8.9

557

4261

ZY000

NOMESCO Finland

Hospital inpatient

2.3

8.9

261

D82

ICPC

Teeth/gum disease

0.8

8.8

1842

20987

A10AE05

ATC

insulin detemir; parenteral

1.4

8.8

351

2498

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.5

8.7

220

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.6

8.7

179

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1.8

8.7

127

715

NG1AA, ,

SPAT

0.6

8.7

199

3062

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

7.2

8.7

R04.0

ICD-10 Finland

Epistaxis

1.3

8.7

641

5014

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

4.1

8.7

F01.0

ICD-10 Finland

Vascular dementia of acute onset

4.1

8.7

ZX124

NOMESCO Finland

Perfusion of a organ or target

50.0

8.7

H35.6

ICD-10 Finland

Retinal haemorrhage

2.3

8.7

270

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.5

8.7

225

1471

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.3

8.6

646

5063

P29

ICPC

Psychological sympt/compl other

1.4

8.6

311

2173

N06AX16

ATC

venlafaxine; oral

1.3

8.6

759

6072

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

4.4

8.6

S82.5

ICD-10 Finland

Fracture of medial malleolus

2.0

8.6

476

WX111

NOMESCO Finland

Local infiltration anesthesia

0.5

8.6

103

1862

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.0

8.6

442

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.7

8.5

159

960

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.6

8.5

212

1374

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.0

8.5

451

R3130

NOMESCO Finland

Training in activities of daily lining

20.0

8.5

RT162, ,

NOMESCO Finland

20.0

8.5

Z00.0

ICD-10 Finland

General medical examination

1.2

8.4

1433

12278

ZXM40

NOMESCO Finland

Use of fluorescent substance

7.3

8.4

WX725

NOMESCO Finland

Noninvasive ventilation

1.4

8.4

370

2679

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.3

8.4

466

3503

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.3

8.4

507

3859

N05AH03

ATC

olanzapine; systemic

1.4

8.4

330

2345

43191

ICD-8 Finland

Cerebral haemorrhage, Subduralis non traumatica, hypertonia non indicata

+∞

8.3

I67.7

ICD-10 Finland

Cerebral arteritis, not elsewhere classified

+∞

8.3

PA2AT

NOMESCO Finland

Cerebral artery PTA

+∞

8.3

PA7YT

NOMESCO Finland

Very extensive carotis artery PTA with stent

+∞

8.3

AAC10

NOMESCO Finland

Reinforcement of intracranial aneurysm wall

+∞

8.3

I67.4

ICD-10 Finland

Hypertensive encephalopathy

+∞

8.3

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

3.2

8.3

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

4.0

8.3

RF220, ,

NOMESCO Finland

1.9

8.3

524

P03

ICPC

Feeling depressed

1.4

8.3

417

3087

G43.9

ICD-10 Finland

Migraine, unspecified

1.5

8.3

212

1383

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.5

8.2

216

1416

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.4

8.2

372

2709

C09CA06

ATC

candesartan; oral

1.2

8.2

1783

15604

M05BB03

ATC

alendronic acid and colecalciferol; oral

1.6

8.1

190

1213

SPAT1279

SPAT

Preparation of immediate hospitalisation

1.9

8.1

103

556

V03AE01

ATC

polystyrene sulfonate; oral

1.8

8.1

110

607

K99

ICPC

Cardiovascular disease other

1.5

8.1

219

1445

Z72.0

ICD-10 Finland

Tobacco use

1.7

8.1

135

792

M25.5

ICD-10 Finland

Pain in joint

0.9

8.1

1732

19710

XA800, ,

SPAT

11.7

8.1

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.6

8.0

173

1084

3314A

ICD-9 Finland

Other cerebral degenerations, Obstructive hydrocephalus

22.0

8.0

Z10.0

ICD-10 Finland

Occupational health examination

0.6

8.0

166

2607

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

8.0

620

4883

9440/3-C71.9

ICD-O-3

Glioblastoma, NOS, of brain, NOS

6.3

8.0

S02.40

ICD-10 Finland

Fracture of malar and maxillary bones, closed

2.1

8.0

372

F06.32

ICD-10 Finland

Organic depression

4.1

8.0

R74

ICPC

Upper respiratory infection acute

0.8

7.9

1313

15273

ZY010

NOMESCO Finland

Hospital outpatient

1.5

7.9

244

1654

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

7.9

2331

20859

Z75.0

ICD-10 Finland

Medical services not available in home

3.3

7.9

137

Kela drug reimbursment

Uraemia requiring dialysis

2.2

7.8

263

S01.3

ICD-10 Finland

Open wound of ear

1.9

7.8

457

N06AX21

ATC

duloxetine; oral

1.3

7.8

711

5711

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.6

7.8

162

1006

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

3.5

7.8

XF620

NOMESCO Finland

Examination of circulation with color method

3.5

7.8

WX320

NOMESCO Finland

Spinalanesthesy

0.8

7.8

1516

17390

N06AX26

ATC

vortioxetine; oral

1.4

7.8

375

2760

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

1.8

7.7

112

631

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.4

7.7

379

2797

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.5

7.7

211

1397

R5130, ,

SPAT

2.7

7.7

150

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

2.3

7.7

240

AAD12

NOMESCO Finland

Drainage of subdural fluid

6.3

7.7

N03AX12

ATC

[U] gabapentin; oral

1.2

7.7

1125

9506

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.6

7.6

177

1129

ZX122

NOMESCO Finland

Intra-arterial

3.0

7.6

112

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

2.5

7.6

186

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

1.7

7.6

124

723

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.2

7.6

853

7015

G93.5

ICD-10 Finland

Compression of brain

18.3

7.6

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.4

7.6

308

2202

2130

FHL

Ventricular atrial shunt

25.0

7.6

G46.4

ICD-10 Finland

Cerebellar stroke syndrome

25.0

7.6

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.3

7.5

708

5708

R1420, ,

SPAT

2.5

7.5

175

ZXC40

NOMESCO Finland

Use of ultrasound

2.5

7.5

181

L13

ICPC

Hip symptom/complaint

0.8

7.5

1125

13207

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.5

7.5

NC2AA

NOMESCO Finland

Forearm X-ray examination

1.9

7.5

485

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.7

7.5

412

5425

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.3

7.5

721

5832

J96.0

ICD-10 Finland

Acute respiratory failure

1.8

7.5

109

616

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

2.1

7.5

308

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

2.5

7.5

176

SDA03

NOMESCO Finland

Periodontal treatment

0.9

7.4

2147

23924

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.4

7.4

349

2558

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

2.6

7.4

153

PCU93

NOMESCO Finland

Injection of therapeutic or sclerosing agent into bypass from suprarenal abdominal aorta and visceral arteries

80.1

7.4

RT161, ,

NOMESCO Finland

80.1

7.4

S70.0

ICD-10 Finland

Contusion of hip

1.4

7.4

318

2297

QAB00

NOMESCO Finland

Suture of skin of head or neck

1.9

7.4

488

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.9

7.4

2681

29416

J01CA08

ATC

pivmecillinam; oral

1.1

7.4

2767

25158

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

2.0

7.3

398

34510

ICD-8 Finland

Epilepsy, """"Grand mal""""

4.0

7.3

N02AX02

ATC

tramadol; systemic, rectal

1.1

7.3

3538

32675

N03AX22

ATC

perampanel; oral

8.3

7.3

G942, I600,

ICD-10 Finland

+∞

7.3

G942, I606,

ICD-10 Finland

+∞

7.3

G46.0*I66.0

ICD-10 Finland

Middle cerebral artery syndrome

+∞

7.3

YGA00

NOMESCO Finland

Excision of one or both lungs from cadaver donor

+∞

7.3

S02.01

ICD-10 Finland

Fracture of the upper part of the head open

9.3

7.3

R20.2

ICD-10 Finland

Paraesthesia of skin

1.4

7.3

380

2834

XF600

NOMESCO Finland

Bloodpressure measurement

1.3

7.2

447

3415

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

0.7

7.2

313

4272

L03

ICPC

Low back symptom/complaint

0.9

7.2

1570

17870

40199

ICD-8 Finland

Essential benign hypertension

1.6

7.2

168

1073

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.4

7.2

204

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.5

7.2

190

1251

34599

ICD-8 Finland

Epilepsy, Other and unspecified

2.7

7.2

133

N06AA09

ATC

amitriptyline; systemic

1.3

7.1

671

5411

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

2.4

7.1

198

SPAT1172

SPAT

Guidance concerning hydration

1.5

7.1

219

1486

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

3.9

7.1

N03AG06

ATC

tiagabine; oral

20.0

7.1

AA1DD

NOMESCO Finland

Head and neck CT

2.8

7.1

117

J69.1

ICD-10 Finland

Pneumonitis due to oils and essences

12.0

7.1

RS390, ,

NOMESCO Finland

8.8

7.0

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

1.8

7.0

525

N05AA02

ATC

levomepromazine; systemic

1.5

7.0

240

1664

WX002

NOMESCO Finland

Sedation and analgesia

1.2

7.0

1449

12615

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

1.9

7.0

426

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

1.6

7.0

156

988

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

3.1

7.0

K29

ICPC

Cardiovascular sympt/complt other

1.4

6.9

353

2621

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

1.8

6.9

513

L90

ICPC

Osteoarthrosis of knee

0.7

6.9

305

4149

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.5

6.9

992

SPAT1050

SPAT

Extensive neurological examination

1.6

6.9

140

866

AA3AD

NOMESCO Finland

CT of face

2.1

6.9

311

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.5

6.9

201

1350

SPAT1139

SPAT

Nutrition survey

1.4

6.9

248

1736

N06AX05

ATC

trazodone; oral

1.7

6.9

129

782

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

2.5

6.9

159

RL110, ,

NOMESCO Finland

13.8

6.9

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

4.0

6.9

SPAT1284

SPAT

Extensive health certificate

1.6

6.8

155

985

C07AB03

ATC

atenolol; systemic

1.3

6.8

506

3964

L04AD01

ATC

ciclosporin; systemic

1.8

6.8

552

M01AB05

ATC

diclofenac; systemic, rectal

0.9

6.8

4632

49056

Z43.5

ICD-10 Finland

Attention to cystostomy

2.1

6.8

273

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

0.8

6.8

426

5506

R60.0

ICD-10 Finland

Localized oedema

1.2

6.8

1043

8848

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

1.6

6.8

162

1042

PBC09

NOMESCO Finland

Suture of brachial artery

6.7

6.8

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.5

6.8

199

1339

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

1.6

6.8

141

878

PA2BM

NOMESCO Finland

MRI examination of vessels in the head with 3 Tesla magnet

10.9

6.8

N03AF04

ATC

eslicarbazepine; oral

10.9

6.8

SPAT1167

SPAT

Insertion of urinary catheter

1.4

6.8

282

2027

F32

ICD-10 Finland

Depressive episode

1.4

6.8

240

1676

ZX120

NOMESCO Finland

Intravenous

1.3

6.8

651

5266

N06AB06

ATC

sertraline; oral

1.3

6.8

600

4808

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

0.8

6.8

686

8368

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.3

6.7

403

3067

RF110, ,

NOMESCO Finland

3.6

6.7

N05AD01

ATC

haloperidol; systemic

1.4

6.7

254

1795

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.8

6.7

511

S02.80

ICD-10 Finland

Fractures of other skull and facial bones, closed

3.1

6.7

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.5

6.7

178

1174

C09AA04

ATC

perindopril; oral

1.3

6.7

393

2985

Q28.0

ICD-10 Finland

Arteriovenous malformation of precerebral vessels

22.5

6.7

2133

FHL

Suntin revisio

22.5

6.7

J01FF01

ATC

clindamycin; systemic

1.1

6.7

1941

17333

RS311, ,

NOMESCO Finland

2.9

6.6

105

S01GX01

ATC

cromoglicic acid; ophthalmic

0.8

6.6

808

9670

Angiography of the heart and coronary arteries

1.3

6.6

564

4501

R01AD08

ATC

fluticasone; nasal

0.9

6.6

1434

16326

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

1.6

6.5

134

833

R053, ,

ICD-10 Finland

0.5

6.5

1233

N18.8

ICD-10 Finland

Other chronic renal failure

1.5

6.5

197

1337

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.7

6.5

306

4114

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.8

6.4

572

7081

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

5.3

6.4

RT163, ,

NOMESCO Finland

69.9

6.4

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

0.7

6.4

172

2552

S42.4

ICD-10 Finland

Fracture of lower end of humerus

1.9

6.4

432

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.6

6.4

124

1971

AAA00

NOMESCO Finland

Exploratory craniotomy

14.3

6.4

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.5

6.4

185

1243

NA3BG, ,

SPAT

0.6

6.4

1421

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.2

6.4

676

5528

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

1.9

6.3

405

F05.1

ICD-10 Finland

Delirium superimposed on dementia

1.9

6.3

391

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.1

6.3

1989

17846

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

3.0

6.3

SPAT1313

SPAT

Guidance and counselling related to accident prevention

2.3

6.3

197

K70.4

ICD-10 Finland

Alcoholic hepatic failure

2.7

6.3

119

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

6.3

1170

10091

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.7

6.3

320

4258

R01AD09

ATC

mometasone; nasal

0.9

6.3

2526

27607

R1250, ,

SPAT

1.5

6.3

200

1369

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

1.9

6.3

378

5CM18, ,

NOMESCO Finland

2.8

6.3

108

N74

ICPC

Malignant neoplasm nervous system

5.5

6.3

ZXF00

NOMESCO Finland

Interruption caused by intraoperative deterioration of general condition

2.6

6.3

131

44209

ICD-8 Finland

Other aneurysm, Ruptura non indicata

18.0

6.3

A10BB12

ATC

glimepiride; oral

1.3

6.3

590

4763

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

2.0

6.3

344

N05BA02

ATC

chlordiazepoxide; systemic

1.6

6.3

146

936

NG1BG, ,

SPAT

0.5

6.3

1034

G942, I603,

ICD-10 Finland

+∞

6.2

2163

FHL

Proxies. Vascular ligation, big brain

+∞

6.2

Y3090, ,

ICD-8 Finland

+∞

6.2

YQA20

NOMESCO Finland

Excision of skin for allograft from cadaver donor

+∞

6.2

PA2BT

NOMESCO Finland

Cerebral artery extensive PTA

+∞

6.2

TQW40, ,

SPAT

0.8

6.2

440

5598

N18.0

ICD-10 Finland

End-stage renal disease

1.8

6.2

436

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

2.3

6.2

192

4329X

ICD-9 Finland

Other and unspecified intracranial haemorrhage, Unspecified intracranial haemorrhage

26.7

6.2

C02DE03, ,

ATC

26.7

6.2

C50

ICD-10 Finland

Malignant neoplasm of breast

0.5

6.2

1045

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.2

6.2

670

5491

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.7

6.2

104

614

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.3

6.2

199

N03AX11

ATC

topiramate; oral

1.7

6.2

570

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.5

6.1

167

1108

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.7

6.1

149

2254

EBA30

NOMESCO Finland

Extraction of root of tooth

1.3

6.1

413

3199

G45.3

ICD-10 Finland

Amaurosis fugax

1.6

6.1

124

769

Z54.8

ICD-10 Finland

Convalescence following other treatment

2.6

6.1

127

N17

ICPC

Vertigo/dizziness

1.2

6.1

958

8145

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

0.8

6.1

398

5111

K92.0

ICD-10 Finland

Haematemesis

1.5

6.1

183

1240

F06.7

ICD-10 Finland

Mild cognitive disorder

1.4

6.1

260

1880

J01MA02

ATC

ciprofloxacin; systemic

1.1

6.1

3313

30730

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

1.9

6.1

362

G03FA12

ATC

medroxyprogesterone and estrogen; systemic

0.7

6.1

159

2367

P76

ICPC

Depressive disorder

1.4

6.0

272

1984

UKC02

NOMESCO Finland

Cystoscopy

1.2

6.0

1458

12839

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.1

6.0

2926

26960

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.4

6.0

291

2148

E883A

ICD-9 Finland

Fall into hole or other opening in surface

1.3

6.0

334

2518

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4652

25580

2.53

307.65

2.8

2.1

248.32

229.36

u/l

0.35

4515

23797

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3049

11880

3.26

307.65

2.4

2.0

29.07

30.06

15.08

2986

11530

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

478

619

8.06

307.65

3.2

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

620

1416

4.60

249.63

2.7

1.4

18076.53

928.26

e6/l

2.16

500

1129

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

615

1399

4.62

248.84

2.7

1.3

107.02

29.83

e6/l

2.31

487

1044

(3036489) Thrombin time

797

2273

3.72

237.19

2.3

2.0

20.68

21.52

3.51

746

2011

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

304

385

8.11

224.14

2.0

2.1

—

(3003396) Base excess in Arterial blood by calculation

2144

11076

2.19

201.78

10.7

6.8

1.23

0.96

mmol/l

2.59

1772

9000

(3019977) pH of Arterial blood

2147

11118

2.19

200.73

10.8

6.9

7.42

0.72

1339

6129

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

607

1626

3.91

197.02

2.0

1.3

808.67

571.09

mg/l

2.36

579

1545

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2143

11166

2.17

196.79

10.9

6.9

5.08

5.06

kpa

0.34

2066

10689

(3027801) Oxygen [Partial pressure] in Arterial blood

2141

11162

2.17

196.26

10.9

6.9

12.69

11.94

kpa

7.69

2066

10676

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2518

14765

1.94

162.95

3.5

3.2

0.82

mmol/l

1.68

2378

13764

(3032080) INR in Blood by Coagulation assay

5667

42706

1.76

157.71

18.8

17.8

1.33

inr

0.23

4917

35898

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

223

306

7.43

153.27

3.9

1.2

—

(3016502) Oxygen saturation in Arterial blood

1851

10015

2.04

149.25

11.6

7.1

95.77

95.25

2.95

1793

9629

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1731

9159

2.08

148.24

12.4

7.6

120.66

119.90

g/l

0.84

1700

8932

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

496

1437

3.58

142.90

1.8

1.3

3.83

3.78

mmol/l

0.39

461

1351

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

185

225

8.36

140.87

2.5

2.3

54.20

50.12

umol/l

0.66

146

191

(3009466) Valproate [Moles/volume] in Serum or Plasma

357

877

4.18

129.95

3.8

5.0

344.00

343.74

umol/l

0.01

302

755

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2040

12141

1.85

121.12

6.6

5.6

1.00

1.05

mmol/l

8.95

1910

11176

(3023410) Appearance of Cerebral spinal fluid

274

582

4.81

119.86

3.5

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

248

487

5.20

118.89

2.0

1.2

2.85

2.19

mmol/l

5.44

223

458

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

166

221

7.62

117.12

3.4

2.9

30.59

28.28

umol/l

1.55

133

163

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1212

6172

2.10

112.68

13.5

8.4

1.34

1.31

0.59

1207

6126

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1178

5956

2.11

111.56

13.8

8.7

0.66

0.63

1.98

1172

5911

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

585

2165

2.81

111.02

2.9

2.4

3.62

3.61

g/l

0.10

566

2060

(3023368) Bacteria identified in Blood by Culture

3764

27086

1.63

110.22

4.8

4.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1183

6072

2.08

107.39

11.6

6.4

24.74

24.44

mmol/l

1.84

1139

5804

(3013826) Glucose [Moles/volume] in Serum or Plasma

6192

50392

1.60

106.42

8.6

5.0

7.05

6.84

mmol/l

10.77

5997

47928

(3020779) Urea [Moles/volume] in Serum or Plasma

1533

8757

1.89

101.75

8.1

6.7

8.95

11.31

mmol/l

29.28

1449

8282

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1091

5569

2.08

100.14

12.1

8.5

24.38

24.25

mmol/l

0.65

1067

5412

(3033658) Prothrombin time (PT) actual/Normal

2974

20583

1.63

99.58

5.4

4.2

84.35

85.69

2.17

2910

20131

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

12.85

96.37

1.9

3.8

44.09

39.62

umol/l

0.73

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

505

1877

2.78

94.84

3.0

2.4

197.20

206.29

1.33

494

1774

(3018405) Lactate [Moles/volume] in Arterial blood

705

3139

2.34

90.62

6.9

3.7

1.40

1.42

mmol/l

0.11

693

3078

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1413

8179

1.85

88.99

2.5

2.4

5.96

6.97

ug/l

1.67

1225

6998

(3023183) Ammonium ion [Moles/volume] in Plasma

456

1709

2.75

84.17

2.6

32.76

34.45

umol/l

0.65

411

1516

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

508

2022

2.59

83.18

2.7

2.2

92.98

89.13

3.36

498

1941

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

19.51

82.42

2.2

1.2

54.05

22.24

2.88

(3020191) Ethanol [Moles/volume] in Serum or Plasma

208

498

4.24

78.27

1.5

1.3

1.03

1.16

promille

0.53

151

393

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

153

289

5.36

76.63

1.9

1.2

48.32

65.48

1.99

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2341

16322

1.57

71.56

2.1

1.9

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

9.61

70.91

2.1

1.2

32.91

67.81

5.47

(3026008) Bacteria identified in Urine by Culture

3707

28606

1.47

69.35

4.0

3.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1372

8430

1.73

69.19

10.7

6.7

1.38

1.39

mmol/l

0.09

1342

8241

(3020891) Body temperature

853

4534

1.96

68.78

7.4

4.3

36.91

°c

0.02

845

4481

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5009

40982

1.45

68.52

9.9

6.4

1.19

1.21

mmol/l

47.21

4711

37484

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4357

34771

1.45

67.88

4.9

4.1

65.46

101.69

ng/l

0.96

3640

26586

(3000991) Gas panel - Venous blood

1310

8057

1.72

65.57

12.4

7.9

—

(3044640) Blood type and Crossmatch panel - Blood

3545

27463

1.45

63.37

2.8

2.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1027

5947

1.81

63.23

12.2

7.4

24.45

24.80

mmol/l

2.41

1010

5898

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

650

3240

2.08

62.56

2.3

2.2

522.71

669.29

ug/l

0.57

623

3079

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

114

199

5.78

62.18

1.6

1.2

24.70

24.00

0.04

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

642

3202

2.07

61.68

3.4

2.7

0.34

iu/ml

0.20

382

1704

(3003181) Sodium [Moles/volume] in Urine

436

1862

2.40

61.23

1.5

1.3

80.59

60.45

mmol/l

11.67

359

1480

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2776

20713

1.47

59.51

2.8

2.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1794

12235

1.57

58.87

2.0

1.8

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

103

173

6.00

58.47

1.1

1.2

87.60

85.96

0.15

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

103

175

5.93

57.79

1.2

1.3

88.57

86.78

0.13

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1685

11414

1.57

56.73

2.0

1.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5408

45864

1.39

54.72

10.7

7.1

1.20

1.21

mmol/l

31.06

4806

39144

(1761868) Lipid panel - Serum or Plasma

1853

25612

0.66

54.24

3.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1465

9832

1.57

50.82

4.5

3.7

5.86

5.81

kpa

1.13

1425

9580

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

312

1264

2.51

49.10

5.4

6.3

11.49

12.36

mg/l

2.32

289

1156

(3024354) Oxygen [Partial pressure] in Venous blood

1254

8177

1.61

49.03

3.8

3.2

4.66

4.38

kpa

4.33

1216

7950

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

897

5363

1.74

48.92

12.8

9.0

16.04

15.86

1.19

864

5162

(3012544) pH of Venous blood

1458

9975

1.54

46.03

4.6

3.8

7.38

1.77

902

5836

(3002032) Base excess in Venous blood by calculation

1408

9561

1.55

45.99

4.6

3.8

1.87

1.80

mmol/l

0.32

1249

8310

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

815

4833

1.75

45.65

1.6

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

115

6.47

45.40

1.1

1.2

77.87

73.83

0.25

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2484

31702

0.71

44.78

1.9

1.38

1.33

mmol/l

1.48

2135

25930

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

117

6.36

44.66

1.2

84.56

77.24

0.35

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4535

38439

1.33

40.70

3.1

2.9

—

estimate

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

191

4.74

39.55

1.5

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2293

17750

1.38

36.61

4.6

4.1

330.60

504.22

ng/l

1.50

1989

15023

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

801

5057

1.63

35.17

4.2

4.1

50.30

45.83

5.28

787

4977

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

726

4472

1.67

35.10

7.7

4.8

1.60

1.57

0.45

683

4242

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6811

73802

0.76

34.42

5.1

5.2

1.40

1.45

mmol/l

16.81

6318

66919

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6893

74423

0.76

32.64

5.2

5.3

4.31

4.53

mmol/l

54.13

6431

68003

(3004119) Hemoglobin [Mass/volume] in Venous blood

914

6061

1.56

32.53

3.8

3.3

127.18

127.47

g/l

0.14

894

5886

(40768804) Tissue Pathology biopsy report

2687

32688

0.76

31.91

2.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

660

4114

1.65

30.38

8.2

5.0

0.90

0.87

1.34

623

3886

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

349

3.29

30.21

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

272

5402

0.49

30.11

2.0

2.1

3.52

3.48

ratio

0.21

220

4297

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7101

76102

0.77

29.49

6.0

6.1

2.44

2.61

mmol/l

51.89

6604

69293

(3011397) Hemoglobin [Presence] in Urine by Test strip

2533

20464

1.32

29.30

4.5

4.0

0.23

0.35

0.22

281

(3027273) Bicarbonate [Moles/volume] in Venous blood

714

4580

1.60

29.24

4.1

3.5

25.32

25.13

mmol/l

0.85

692

4439

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

6860

73808

0.77

29.03

24.0

18.4

76.13

74.16

ml/min/173m2

11.39

6493

68891

(3008295) Osmolality of Serum or Plasma

226

1014

2.26

28.38

1.6

1.3

281.13

275.71

mosm/kgh2o

2.79

174

752

(3045716) Anion gap in Serum or Plasma by calculation

220

984

2.26

27.84

3.8

2.9

10.92

10.63

mmol/l

0.46

214

971

(3019309) Folate [Moles/volume] in Red Blood Cells

2208

17708

1.32

26.46

1.8

1204.68

1167.80

nmol/l

1.08

1746

13199

(3018418) pH of Serum or Plasma

3272

27647

1.27

26.15

5.0

4.2

7.40

1.98

2413

19836

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6993

74718

0.78

25.27

5.4

5.6

6.13

6.05

mmol/l

4.42

6364

67273

(3019150) Specific gravity of Urine by Refractometry

2409

19655

1.30

25.22

5.1

4.5

1.02

1.17

kg/l

0.81

1603

13299

(3047181) Lactate [Moles/volume] in Blood

460

2783

1.68

23.72

10.2

5.7

1.41

1.33

mmol/l

0.64

402

2461

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

499

3087

1.65

23.62

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

640

4210

1.56

23.43

2.4

1.9

2.59

2.35

ug/l

0.13

534

3695

(3024561) Albumin [Mass/volume] in Serum or Plasma

4614

40923

1.24

23.13

5.9

5.0

33.86

34.86

g/l

26.77

4301

37985

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

189

3884

0.48

23.02

1.7

1.8

3.32

3.43

mmol/l

0.60

138

2772

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

853

5984

1.46

22.92

1.9

1.8

—

(3026782) Osmolality of Urine

2214

18071

1.29

22.72

3.6

3.1

529.52

531.54

mosm/kgh2o

0.17

1996

15851

(3031040) Bacteria [#/volume] in Urine by Automated count

6086

55700

1.24

22.33

6.2

5.2

1851.05

2243.99

e6/l

0.26

107

910

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

324

3.01

22.32

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6867

73231

0.80

22.23

7.1

7.0

40.65

40.09

mmol/mol

5.08

6370

67272

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7649

80529

0.78

21.88

14.4

12.7

25.88

25.43

u/l

0.52

7412

77634

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

784

5465

1.47

21.74

4.6

3.8

24.22

24.14

mmol/l

0.27

769

5397

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

964

6998

1.42

21.49

1.9

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

1317

10118

1.35

20.71

2.0

1.8

—

(3039000) Anion gap in Blood by calculation

335

1939

1.75

20.31

11.8

6.6

11.07

11.35

mmol/l

0.66

304

1730

(3018572) Chloride [Moles/volume] in Blood

335

1940

1.75

20.28

11.8

6.6

104.91

104.99

mmol/l

0.09

304

1732

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

181

857

2.13

20.01

1.4

1.2

3.36

3.68

u/ml

0.10

287

(3000850) Epithelial cells [#/volume] in Urine

2481

20891

1.25

19.08

3.4

2.8

5.20

4.98

e6/l

0.43

2319

19005

(3042936) Bacteria identified in Isolate by Culture

1603

12817

1.30

18.84

2.2

2.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

764

5460

1.43

18.51

4.2

3.5

1.96

2.00

mmol/l

0.09

533

4013

(21494755) Public health laboratory ask at order entry panel

225

4052

0.54

18.12

1.4

—

(3016038) Potassium [Moles/volume] in Urine

145

656

2.23

18.01

1.2

1.1

31.23

35.04

mmol/l

1.33

125

552

(3010813) Leukocytes [#/volume] in Blood

7910

82582

0.79

17.96

37.0

27.8

7.25

6.88

e9/l

28.25

7727

80197

(3000963) Hemoglobin [Mass/volume] in Blood

7910

82582

0.79

17.96

37.3

28.0

130.20

133.19

g/l

55.27

7813

81423

(3026361) Erythrocytes [#/volume] in Blood

7909

82572

0.79

17.96

37.0

27.8

4.32

4.41

e12/l

49.50

7722

80198

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1338

10503

1.32

17.95

10.0

7.9

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

7909

82570

0.79

17.93

38.2

28.2

38.93

39.92

16.84

7800

81340

(3007461) Platelets [#/volume] in Blood

7908

82559

0.79

17.92

37.0

27.8

243.13

242.74

e9/l

0.19

7736

80509

(3024731) MCV [Entitic mean volume] in Red Blood Cells

7909

82567

0.79

17.90

36.9

27.7

91.84

91.64

3.15

7802

81386

(3010375) cycloSPORINE [Mass/volume] in Blood

283

2.91

17.90

31.6

28.4

100.39

110.08

ug/l

0.92

232

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

171

828

2.08

17.88

1.4

1.2

3.77

3.60

u/ml

0.08

362

(3035941) MCH [Entitic mass]

7909

82565

0.79

17.88

36.9

27.7

30.47

30.42

1.73

7802

81382

(3029937) Albumin [Presence] in Urine by Test strip

2935

25313

1.23

17.80

5.2

4.4

0.00

estimate

0.06

838

8488

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6646

70602

0.82

17.53

4.5

4.4

1.30

1.28

mmol/l

1.25

6113

63175

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.86

17.40

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

975

7353

1.36

17.14

2.1

2.3

390.16

383.66

nmol/l

0.45

894

6748

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1591

19396

0.79

16.59

3.2

3.5

0.88

0.81

ug/l

1.05

1132

13533

(3002582) Erythrocytes [#/volume] in Urine

3389

29855

1.20

16.17

4.3

3.6

70.58

103.74

e6/l

1.65

2783

23074

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

5.01

15.68

1.0

1.2

—

mmol/l

—

(4034850) Laboratory test

392

2531

1.57

15.60

12.6

11.8

—

(4198724) Urine methamphetamine measurement

154

3.45

15.43

1.5

—

(3009343) pH of Capillary blood

831

6230

1.36

15.12

4.4

3.7

7.41

7.42

1.74

708

5176

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

851

6412

1.36

14.99

4.4

3.7

5.21

5.16

kpa

0.81

786

6078

(3015736) pH of Urine

3939

35378

1.19

14.74

4.2

3.7

6.41

6.25

15.28

2080

19438

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

108

471

2.31

14.72

2.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

379

2465

1.56

14.63

3.8

3.1

8.12

7.91

kpa

1.65

352

2415

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2095

17763

1.23

14.46

2.2

1.7

1.66

1.48

mg/l

1.49

1718

13954

(3040151) Glucose [Moles/volume] in Capillary blood

203

1127

1.82

14.29

8.6

6.0

7.81

7.24

mmol/l

0.91

167

921

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

320

2.57

14.24

1.5

2.0

73.41

125.20

umol/l

1.61

172

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

153

775

1.99

14.24

1.2

1.1

116.08

115.45

0.08

146

684

(36304419) Bacteria [Presence] in Urine

2764

24179

1.20

13.68

4.1

3.4

0.00

119.71

estimate

—

132

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

5827

62055

0.85

13.12

30.9

22.8

14.01

13.86

12.23

5750

61170

(4268621) Lupus anticoagulant assay

123

595

2.08

13.03

2.5

2.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

485

3410

1.44

12.85

2.1

1.8

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

7885

81803

0.83

12.78

32.3

24.6

82.88

82.97

umol/l

0.06

7773

80571

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4981

45942

1.17

12.75

6.9

6.6

11.75

12.40

umol/l

2.72

4751

43711

(3052851) Hemolysis interference index of Serum or Plasma

370

2471

1.52

12.70

3.8

3.4

1.95

1.83

index

0.11

198

1281

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1084

8644

1.28

12.69

2.4

2.2

0.20

g/l

0.06

1005

7998

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

125

3.45

12.57

1.1

1.3

—

(3021901) Oxygen saturation in Capillary blood

324

2110

1.55

12.49

3.4

3.0

89.47

89.00

0.55

298

2060

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3126

27843

1.18

12.27

3.0

2.7

60.95

65.14

u/l

0.60

2927

25704

(3028271) Lactate [Moles/volume] in Capillary blood

247

1514

1.65

12.27

2.0

1.9

1.92

1.68

mmol/l

2.42

214

1480

(4195642) Thrombophilia screening test

146

770

1.91

12.15

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2942

32926

0.85

12.06

5.3

6.0

6.89

3.86

ug/l

0.63

2638

29490

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

153

823

1.87

11.99

1.2

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

513

3694

1.41

11.92

2.3

2.0

—

(3002256) Pathology report gross observation

928

11647

0.78

11.87

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

2904

25777

1.18

11.77

4.2

3.4

0.46

0.45

e6/l

0.10

2331

19221

(3001019) Free T4 and TSH panel - Serum or Plasma

118

2253

0.52

11.63

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6793

71225

0.85

11.56

5.4

5.3

1.98

2.02

mu/l

1.50

6257

64583

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

287

2.48

11.55

1.3

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

476

3417

1.41

11.27

3.4

3.0

24.73

24.85

mmol/l

0.28

451

3360

(3022145) Colonoscopy Study observation

748

9586

0.76

11.21

1.3

1.4

—

(3024928) Oxygen saturation in Venous blood

336

2264

1.50

11.10

3.7

2.9

62.83

60.16

1.32

315

2186

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

136

3.17

11.05

1.7

2.0

1.17

1.19

mmol/l

0.55

131

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

148

3.05

10.84

1.9

1.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

173

2.84

10.43

1.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

308

2069

1.50

10.35

2.9

2.7

16.53

16.00

2.23

275

2036

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

180

2.79

10.28

1.0

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1859

16042

1.19

10.25

3.4

3.2

1.16

1.30

e6/l

0.30

1108

8779

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

148

2.98

10.22

1.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

151

852

1.78

10.21

1.6

1.7

—

(3014271) Vancomycin [Susceptibility]

105

527

2.00

10.17

3.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1644

0.48

10.15

1.2

1.51

1.52

g/l

0.22

1644

(3006184) Hemoglobin [Mass/volume] in Capillary blood

339

2335

1.47

10.07

2.4

2.3

130.26

126.65

g/l

1.54

252

1826

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

887

7097

1.27

10.06

1.9

1.7

1.70

1.50

7.74

757

6064

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2915

26144

1.16

10.01

3.8

3.3

36.36

35.14

u/l

0.39

2744

24452

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

183

2.74

9.97

1.0

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

271

2.41

9.95

43.7

35.4

7.26

7.22

ug/l

0.05

235

(3011985) Renin [Units/volume] in Plasma

188

1138

1.66

9.90

1.3

1.4

51.38

59.87

mu/l

0.28

170

1017

(3013512) EKG study

2838

31495

0.86

9.88

4.4

4.0

0.75

0.77

—

(3018095) Leukocytes [#/volume] in Urine

3608

32931

1.15

9.65

5.0

4.1

116.79

118.30

e6/l

0.03

2827

23873

(3017143) Hepatitis C virus Ab [Presence] in Serum

863

6919

1.27

9.62

1.8

1.5

—

(3042733) HLA Ab [Presence] in Serum

193

2.65

9.56

5.3

4.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

106

551

1.93

9.32

1.7

1.9

7.88

8.11

mmol/l

0.32

106

551

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2363

26488

0.86

9.27

4.6

4.9

22.63

22.27

0.51

1188

14130

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1509

0.48

9.24

1.2

0.61

0.62

ratio

0.08

236

(40757494) Bilirubin.total [Moles/volume] in Blood

457

2.02

9.21

2.1

2.3

18.74

37.64

umol/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

737

9233

0.78

9.19

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

175

1070

1.65

8.91

1.4

1.3

294.16

307.56

pmol/l

0.14

148

900

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

4.19

8.89

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

155

2.78

8.87

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

100

521

1.93

8.76

2.6

2.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

168

2.69

8.69

1.0

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1056

12636

0.82

8.69

1.3

17.35

12.23

u/ml

0.48

402

4548

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.46

8.61

1.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

143

838

1.72

8.56

3.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

147

2.80

8.55

1.5

2.0

1.17

1.19

mmol/l

0.55

142

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

314

4374

0.71

8.19

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.27

8.18

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

542

6929

0.77

7.94

2.3

11.80

12.67

nmol/l

1.38

452

6135

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

135

796

1.70

7.93

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

4747

44513

1.13

7.76

4.9

4.2

5.53

4.06

estimate

0.21

999

9759

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

280

1974

1.43

7.46

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

280

1974

1.43

7.46

1.4

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

4682

43938

1.12

7.42

4.9

4.2

0.00

estimate

2.33

962

9422

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

616

4895

1.27

7.41

1.6

1.7

1.52

1.56

g/l

0.43

526

4164

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

545

1.82

7.39

1.1

—

(3024932) HLA-DR beta [Type]

177

2.49

7.37

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

662

8183

0.80

7.35

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

365

2701

1.36

7.32

2.0

1.7

—

(3017569) Oxygen content in Arterial blood

102

569

1.80

7.30

1.7

2.3

15.69

15.78

0.10

102

569

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

192

1262

1.53

7.28

3.5

2.5

1511.83

1612.23

u/ml

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1672

14680

1.17

7.27

3.7

3.3

2.46

2.42

e6/l

0.07

920

7403

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.48

7.24

1.0

1.1

—

(40768446) Kidney Pathology biopsy report

255

2.20

7.12

1.9

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

323

2356

1.38

7.09

1.5

1.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2716

24754

1.13

6.87

2.5

2.4

3.17

2.95

mg/l

3.56

2339

21219

(3024471) HLA-A [Type]

184

2.40

6.82

1.0

—

(3009261) Glucose [Presence] in Urine by Test strip

4755

44802

1.12

6.78

4.9

4.3

0.02

0.37

estimate

1.17

935

9138

(3008037) Lactate [Moles/volume] in Venous blood

346

2572

1.36

6.77

3.6

3.4

1.81

1.65

mmol/l

1.22

335

2499

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1149

9838

1.19

6.76

3.1

2.7

9.07

9.61

umol/l

0.33

1020

8631

(40768797) Stomach Pathology biopsy report

991

11650

0.83

6.70

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.29

6.67

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

174

2.42

6.65

1.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

7.78

6.60

1.1

1.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1172

13560

0.85

6.58

1.3

55.85

36.03

iu/ml

1.56

342

4114

(3002079) Sodium [Moles/time] in 24 hour Urine

318

2.02

6.53

1.2

1.3

147.88

170.76

mmol/24h

1.41

318

(3039443) Prostate specific Ag panel - Serum or Plasma

1340

0.54

6.52

1.4

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

414

5333

0.77

6.46

1.2

1.3

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

3.06

6.44

1.1

1.0

9.09

9.02

mg/g

0.02

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

956

8090

1.20

6.41

1.8

1.5

—

(40768793) Breast Pathology biopsy report

110

1786

0.61

6.22

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

877

10345

0.83

6.14

5.1

33.91

32.91

1.74

640

6445

(4094501) Cardiovascular stress test using bicycle ergometer

147

2224

0.66

6.06

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.88

6.02

1.1

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

308

1.99

5.99

1.1

1.07

ratio

0.01

240

(44790047) Parainfluenza type 1 nucleic acid detection

164

1095

1.51

5.87

1.7

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

164

1095

1.51

5.87

1.7

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

164

1095

1.51

5.87

1.7

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

164

1095

1.51

5.87

1.7

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3551

33109

1.11

5.85

5.1

4.3

0.65

0.38

estimate

0.17

796

7710

(3024316) Viscosity of Plasma

5.00

5.85

1.9

1.7

1.59

1.73

mpas

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

587

1.69

5.82

1.7

1.8

—

(3023419) Bacteria identified in Sputum by Culture

182

1246

1.47

5.77

1.8

2.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2080

18828

1.13

5.72

2.9

3.1

2.46

mmol/l

0.10

1830

16755

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

229

1640

1.41

5.69

6.4

5.1

1156.94

1963.75

iu/ml

0.29

247

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

457

1.78

5.68

1.3

1.5

13.30

13.97

umol/l

0.35

423

(40768800) Prostate Pathology biopsy report

153

2259

0.67

5.62

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

960

8235

1.18

5.53

3.5

3.2

252.88

243.02

ng/l

0.28

868

7547

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

265

1955

1.36

5.52

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

343

2631

1.31

5.50

2.0

1.6

0.45

0.32

mg/l

3.23

181

1193

(3030981) Hyaline casts [#/volume] in Urine by Automated count

917

7840

1.19

5.49

2.8

2.6

0.63

0.48

e6/l

0.74

885

7569

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

171

1172

1.47

5.41

1.4

1.2

267.45

282.10

u/ml

0.31

115

720

(3027945) Reticulocytes/Erythrocytes in Blood

1366

12066

1.15

5.40

2.8

2.4

1.88

1.78

1.92

1211

10609

(3010421) pH of Blood

393

3078

1.29

5.40

4.5

3.9

7.41

0.64

377

3032

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.09

5.32

4.3

2.0

—

(3027315) Oxygen [Partial pressure] in Blood

275

2053

1.35

5.32

4.8

4.3

8.36

8.40

kpa

0.20

257

2001

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

3.18

5.30

1.8

1.1

24.11

22.56

—

(3012501) Base excess in Blood by calculation

273

2042

1.35

5.23

4.7

4.3

2.63

2.71

mmol/l

0.18

177

1401

(3013290) Carbon dioxide [Partial pressure] in Blood

273

2044

1.34

5.19

4.7

4.3

5.01

5.00

kpa

0.07

255

1993

(3034426) Prothrombin time (PT)

189

2.17

5.16

1.2

30.50

28.25

0.88

189

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

901

10446

0.85

5.16

3.4

4.2

20.54

28.21

ug/l

0.56

763

8682

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

162

1112

1.46

5.11

1.5

1.3

0.64

3.66

nmol/l

0.93

157

1067

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.84

5.07

2.0

2.2

18.45

17.55

umol/l

0.12

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

165

1141

1.45

5.02

1.5

1.3

0.13

0.27

nmol/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

137

920

1.50

4.85

2.4

1.9

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

141

953

1.49

4.84

1.6

1.3

—

nmol/l

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3304

30934

1.10

4.78

3.4

3.5

2.35

mmol/l

2.64

2964

27776

(3022313) Gas panel - Capillary blood

527

4348

1.22

4.65

4.7

3.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

287

2203

1.31

4.64

1.9

1.5

0.24

g/l

0.62

273

2089

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

170

1206

1.42

4.55

1.5

1.4

155.39

153.78

au/ml

0.06

342

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5711

59240

0.91

4.52

4.2

4.3

15.05

15.02

pmol/l

0.31

5198

53403

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1086

9563

1.15

4.49

4.6

3.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

308

2399

1.29

4.48

1.7

1.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.65

4.47

1.0

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

269

2059

1.31

4.46

1.3

1.2

124.50

137.21

titre

0.07

179

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

299

1.84

4.44

1.0

1.1

1.44

1.15

u/l

0.69

141

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

372

1.75

4.44

1.0

1.1

—

(1002224) Polysomnography panel

201

2706

0.74

4.40

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

106

2.46

4.36

3.3

2.6

62.03

48.00

mg/l

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

253

1927

1.32

4.35

1.5

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

418

3391

1.24

4.34

4.9

3.8

24.90

24.92

mmol/l

0.03

380

3059

(3037121) Protein [Mass/volume] in Urine

387

3113

1.25

4.34

2.8

3.1

360.92

486.55

mg/l

0.91

203

1341

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

188

1369

1.38

4.34

1.6

1.4

—

(3036525) Urea [Moles/time] in 24 hour Urine

3.20

4.32

3.7

3.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

238

1.94

4.32

1.2

1.1

1.40

26.33

u/ml

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

283

3619

0.78

4.28

3.4

4.1

198.03

79.54

u/ml

0.56

272

3467

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

176

1272

1.39

4.26

1.4

1.2

—

90.76

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

284

1.83

4.16

2.8

2.6

0.61

0.62

mmol/l

0.42

284

(3023103) Potassium [Moles/volume] in Serum or Plasma

7851

80143

0.90

4.15

32.2

22.4

3.97

4.00

mmol/l

15.65

7712

78340

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

153

2126

0.72

4.12

1.7

1.9

44.46

43.51

nmol/l

0.17

148

2051

(3011288) Drugs identified in Urine by Screen method Nominal

116

781

1.49

4.12

3.9

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

307

1.80

4.11

1.7

2.3

5.31

4.88

kpa

1.83

307

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

141

987

1.43

4.10

1.5

1.3

0.20

0.21

nmol/l

0.28

106

809

(3052592) Norovirus Ag [Presence] in Stool

174

2.07

4.09

1.4

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

308

1.79

4.07

1.7

2.3

10.60

10.16

kpa

0.23

308

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

144

2015

0.71

4.05

1.7

5.21

4.96

mg/l

0.06

114

1528

(40758292) HTLV I+II Ab panel - Serum

129

2.25

4.04

1.1

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

648

1.53

4.02

1.1

—

(3016879) Cocaine [Presence] in Urine

155

1108

1.40

4.02

2.5

1.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

634

1.53

3.97

1.4

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1803

16513

1.11

3.94

3.1

2.6

11.76

12.29

umol/l

2.06

1651

15190

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.72

3.91

1.0

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

264

2060

1.29

3.85

1.2

858.57

879.68

titre

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

917

8071

1.15

3.83

2.8

2.5

40.56

53.77

u/l

0.58

785

6801

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

288

2279

1.27

3.76

1.9

1.5

1.21

1.18

g/l

0.70

274

2164

(3037467) Urinalysis macro (dipstick) panel - Urine

5881

56840

1.08

3.76

5.7

4.9

1.96

2.44

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

587

1.54

3.74

1.2

242.86

112.00

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

587

1.54

3.74

1.2

112.31

167.03

titre

0.83

101

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

118

1683

0.70

3.74

1.9

207.11

201.94

pmol/l

0.10

109

1571

(1616796) Gas panel - Central venous blood

282

2230

1.27

3.71

4.5

3.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

378

1.67

3.70

9.7

3.4

69.72

65.30

mg/l

0.13

247

(3019550) Sodium [Moles/volume] in Serum or Plasma

7848

80008

0.91

3.69

32.4

22.2

139.28

139.60

mmol/l

17.80

7719

78322

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

646

1.51

3.67

1.4

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

418

1.63

3.64

1.3

1.4

—

(3017732) Neutrophils [#/volume] in Blood

914

10296

0.88

3.56

3.2

3.3

5.09

4.71

e9/l

0.45

773

8659

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

126

1758

0.71

3.54

1.4

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

422

1.62

3.52

1.1

54.58

45.02

mg/l

0.72

352

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3487

36670

0.92

3.47

3.5

3.1

157.40

151.50

ug/l

0.54

3185

33573

(4027681) Cerebrospinal fluid IgG ratio and IgG index

303

1.72

3.42

1.2

0.53

0.54

ratio

0.11

185

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

610

1.50

3.37

2.4

2.3

30.70

25.96

iu/ml

0.21

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

7.00

3.36

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

161

1199

1.35

3.32

2.5

1.9

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

789

6946

1.15

3.32

3.3

2.8

62.72

61.32

ml/min/173m2

0.42

368

3062

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

106

736

1.44

3.30

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

106

736

1.44

3.30

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

106

736

1.44

3.30

1.7

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

1053

9459

1.13

3.24

2.9

2.5

71.29

67.81

e9/l

1.90

775

7060

(3027008) Opiates [Presence] in Urine

161

1207

1.34

3.20

2.4

1.8

—

(3022806) Fractional oxyhemoglobin in Capillary blood

155

1157

1.34

3.17

1.9

88.75

88.97

0.18

141

1142

(3028300) Cannabinoids [Presence] in Urine

161

1209

1.34

3.17

2.5

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1275

11600

1.11

3.14

4.5

4.3

252.47

249.50

u/l

0.20

1198

10932

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

292

2370

1.24

3.13

1.7

1.5

—

(40768443) Skin Pathology biopsy report

343

4131

0.82

3.11

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

119

854

1.40

3.11

3.3

11.94

13.16

index

0.71

461

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

245

1.76

3.09

1.3

1.4

16.18

16.38

pmol/l

0.07

199

(3042517) Benzodiazepines panel - Urine

4.00

3.08

1.4

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5007

48305

1.07

3.06

4.1

3.3

64.91

54.10

u/l

7.59

4727

44255

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

407

1.58

3.04

1.1

351.79

302.15

mg/l

0.88

359

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1563

14396

1.10

3.03

3.2

2.6

21.69

21.73

0.04

1439

13225

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

625

1.46

3.03

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.50

3.03

1.6

1.3

25.98

22.16

mmol/l

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

561

6461

0.86

3.02

1.5

—

(3044889) 12 lead EKG panel

5517

56869

0.93

3.02

4.7

4.5

0.31

3327.73

0.73

130

(43055442) Apixaban [Mass/volume] in Serum or Plasma

175

1.89

2.98

1.3

1.6

66.93

98.72

ug/l

2.04

147

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.75

2.98

1.1

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2870

27156

1.08

2.97

1.8

1.7

18.98

20.14

nmol/l

3.64

2530

22770

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

4.71

2.91

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

551

0.54

2.91

1.0

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

818

7287

1.13

2.91

4.9

3.7

106.87

94.31

ng/l

2.65

690

6142

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

296

1.66

2.88

1.1

1306.42

315.32

ng/l

0.43

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.09

2.87

4.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.43

2.87

1.3

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

684

6029

1.14

2.86

2.5

2.9

10.86

10.62

g/l

0.61

621

5538

(3000093) Morphology [Interpretation] in Blood Narrative

126

932

1.36

2.78

1.2

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

217

2705

0.80

2.78

1.7

1.6

20.00

21.78

u/ml

0.15

534

(3020630) Protein [Mass/volume] in Serum or Plasma

962

8681

1.12

2.77

2.3

2.6

65.35

65.93

g/l

1.51

857

7807

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1672

15517

1.09

2.76

3.2

2.6

2.21

2.27

g/l

3.04

1524

14192

(3027456) Digoxin [Moles/volume] in Serum or Plasma

301

2490

1.21

2.73

3.4

3.3

0.78

0.82

nmol/l

1.00

235

1993

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.00

2.72

2.6

1.9

—

(3038515) Glucose [Moles/volume] in Venous blood

270

2210

1.23

2.72

3.9

3.5

7.89

7.68

mmol/l

0.55

264

2147

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

286

1.65

2.71

1.1

1430.83

1573.22

miu/ml

0.41

286

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1497

16160

0.91

2.70

1.3

1.72

1.83

u/ml

0.13

404

4083

(3006315) Basophils [#/volume] in Blood

4350

41892

1.07

2.67

6.4

6.1

0.04

e9/l

0.89

3771

35369

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

165

2113

0.78

2.67

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

537

4683

1.15

2.64

1.5

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.79

2.64

3.5

3.8

—

(3027944) Amphetamines [Presence] in Urine

154

1184

1.30

2.63

2.5

1.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2166

22978

0.93

2.57

4.6

3.8

0.42

0.38

estimate

0.05

746

7320

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

450

1.49

2.55

1.1

—

0.62

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

110

809

1.36

2.55

1.9

2.1

—

3.90

—

(3001604) Monocytes [#/volume] in Blood

4329

41726

1.07

2.55

6.4

6.1

0.63

0.62

e9/l

3.98

3750

35196

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

362

1.55

2.54

4.3

5.3

1528.00

643.00

u/ml

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.73

2.54

1.0

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

109

803

1.36

2.51

2.1

3348.91

3574.17

u/l

0.04

312

(3006922) Hepatitis E virus Ab [Presence] in Serum

527

1.45

2.48

1.1

—

(3020650) Glucose [Presence] in Urine

270

0.41

2.46

2.0

1.7

0.00

0.03

estimate

1.08

270

(46235355) HIV 1 and 2 tests - Meaningful Use set

999

9117

1.11

2.36

1.9

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

153

1195

1.28

2.36

1.1

—

(44806420) Estimation of glomerular filtration rate

711

0.65

2.34

2.7

2.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.04

2.30

7.5

5.2

54.65

53.66

ug/min

0.02

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

840

7608

1.11

2.30

4.9

4.0

1.22

1.23

mmol/l

2.74

745

6435

(3016650) Hepatitis A virus Ab [Presence] in Serum

148

1157

1.28

2.28

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.48

2.26

1.0

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

4409

42636

1.06

2.25

6.5

6.2

1.79

1.88

e9/l

1.64

3884

36932

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

201

1.69

2.23

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

149

1.81

2.23

2.0

1.8

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

423

1.47

2.23

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

423

1.47

2.23

1.5

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

355

3045

1.17

2.22

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

303

3564

0.85

2.21

3.1

3.4

1046.81

1601.60

u/ml

0.41

258

3062

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.41

2.19

1.1

13.38

15.26

u/l

0.12

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

575

1.39

2.18

1.0

633.02

708.03

ng/l

0.68

383

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2086

19712

1.07

2.18

1.8

27871186.22

28794969.47

pmol/l

0.02

1733

15944

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.13

2.18

1.0

1.3

16.68

21.30

pmol/l

0.21

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

359

4157

0.86

2.17

1.2

109.51

132.94

u/ml

0.44

128

1479

(3048689) Calprotectin [Mass/mass] in Stool

815

8956

0.90

2.15

2.2

190.13

146.91

ug/g

2.09

664

7052

(3014765) Yersinia sp identified in Stool by Organism specific culture

252

2105

1.20

2.15

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

115

1.91

2.14

12.7

12.2

5.35

5.23

mmol/l

0.05

115

(3045788) Cell count panel - Pleural fluid

148

1168

1.27

2.14

1.5

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.30

2.14

1.5

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.16

2.14

1.1

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.62

2.13

2.6

2.4

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

227

1.63

2.13

4.5

6.6

59.96

72.78

1.66

175

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

578

1.39

2.13

1.0

40.30

44.93

ng/l

0.43

389

(3008898) HLA-B27 [Presence]

143

1804

0.79

2.12

1.0

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

252

2111

1.20

2.09

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

438

4985

0.87

2.09

2.4

2.5

—

(3035285) Chloride [Moles/volume] in Venous blood

157

1252

1.26

2.09

2.5

2.4

105.39

105.49

mmol/l

0.09

157

1239

(3041354) Potassium [Moles/volume] in Venous blood

157

1252

1.26

2.09

2.5

2.4

4.06

4.10

mmol/l

0.71

157

1239

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

786

0.69

2.08

1.0

1.1

1.74

3.47

eliau/ml

1.09

287

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.13

2.08

1.1

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

408

0.56

2.07

1.8

36.83

39.92

g/l

1.78

408

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

422

1.45

2.07

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

249

2093

1.19

2.01

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

2.05

2.00

1.6

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

577

1.37

1.99

1.0

330.23

338.26

ng/l

0.07

396

(3033705) Calcium.ionized [Moles/volume] in Venous blood

154

1234

1.25

1.98

2.6

2.5

1.20

mmol/l

0.43

154

1221

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

171

1.70

1.95

1.2

1.3

—

(3013115) Eosinophils [#/volume] in Blood

4444

43106

1.06

1.94

6.7

6.3

0.19

0.20

e9/l

0.56

3893

36964

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3612

37388

0.95

1.93

2.6

2.4

76.61

79.38

nmol/l

7.11

3237

33107

(3007164) IgA [Mass/volume] in Serum or Plasma

1324

14149

0.93

1.90

1.5

2.77

2.60

g/l

1.74

811

8292

(3004451) EKG impression Narrative

591

1.36

1.89

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

223

1868

1.20

1.89

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

473

1.40

1.88

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

473

1.40

1.88

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

804

0.71

1.88

1.2

7.80

7.73

mmol/l

0.05

682

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.18

1.87

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

577

1.35

1.84

1.1

—

(4281824) Cell count and differential, peritoneal fluid

905

0.73

1.84

1.3

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

323

2798

1.16

1.84

1.3

1.2

1.59

1.03

u/ml

0.29

243

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

471

1.38

1.75

1.3

1.2

78.00

84.00

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

357

3129

1.15

1.74

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.33

1.74

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

614

0.68

1.71

1.4

0.25

0.26

nmol/l

0.07

436

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

482

0.64

1.71

1.5

1.4

142.40

181.41

pmol/l

0.98

482

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

266

3084

0.86

1.70

1.8

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

179

2144

0.83

1.69

3.2

3.3

1285.52

772.12

u/ml

0.26

160

1940

(3003694) ABO and Rh group [Type] in Blood

2194

20947

1.06

1.66

1.4

1.3

—

(3012516) Albumin [Mass/volume] in Urine

2878

29860

0.95

1.63

3.6

3.5

81.11

48.23

mg/l

5.71

1991

19200

(3028026) IgM [Mass/volume] in Serum or Plasma

531

4794

1.11

1.62

1.8

1.9

1.35

g/l

0.00

475

4331

(3028679) Herpes simplex virus Ab [Presence] in Serum

302

1.46

1.62

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.57

1.61

7.8

9.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

105

829

1.27

1.60

2.2

4.18

1.41

u/field

1.45

454

(4035726) Immunohistochemistry procedure

722

7850

0.91

1.59

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

190

1.58

1.59

1.3

1.2

—

(40768795) Lymph node Pathology biopsy report

892

0.75

1.58

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

297

3393

0.87

1.57

1.8

1.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

390

4377

0.89

1.57

1.3

275.94

263.58

u/ml

0.05

361

4037

(3044009) aPTT.lupus sensitive (LA screen)

2.27

1.55

1.2

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

156

1293

1.21

1.54

1.4

53919.44

64490.29

e6/l

0.23

731

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

160

0.44

1.53

1.0

1.2

—

(3033086) Enterovirus Ab [Titer] in Serum

3.33

1.52

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

239

2059

1.16

1.52

1.5

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

141

0.43

1.51

1.3

1.8

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.59

1.51

1.9

5.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3223

31166

1.05

1.51

3.4

3.3

1812.57

1752.43

ng/l

0.29

2829

27198

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.86

1.49

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

184

0.49

1.49

1.1

1.8

—

0.94

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

167

1981

0.84

1.46

1.8

41.21

4.03

iu/l

0.48

750

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

497

1.33

1.45

1.2

1.1

36.61

25.29

u/l

0.54

437

(3013650) Neutrophils [#/volume] in Blood by Automated count

4821

47092

1.05

1.44

9.3

9.5

4.54

4.30

e9/l

7.38

4228

40424

(3020356) Listeria sp identified in Specimen by Organism specific culture

3.12

1.43

1.0

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

2.73

1.43

5.7

5.6

459.67

388.14

umol/l

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

320

3610

0.88

1.43

1.1

1.12

1.49

u/ml

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

278

2435

1.15

1.43

1.4

9.12

15.31

iu/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

197

1682

1.17

1.42

1.4

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

149

1.61

1.40

1.2

1.1

0.89

0.66

umol/24h

0.97

(3014051) Protein [Presence] in Urine by Test strip

2158

22472

0.95

1.39

3.5

3.2

0.08

0.07

0.08

733

(4146454) Self-monitoring of blood glucose

1039

0.79

1.37

2.3

2.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

120

0.42

1.37

1.2

1.0

43.32

37.73

iu/ml

—

120

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.61

1.36

1.0

1.2

—

mmol/l

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

5868

59701

0.96

1.36

4.6

4.5

15.20

14.00

mm/h

6.18

5508

54978

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

347

0.63

1.35

1.1

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

202

2340

0.86

1.34

1.6

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

412

3715

1.11

1.34

1.5

1.6

10.32

18.22

iu/ml

1.28

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.13

1.33

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

192

1.51

1.31

1.8

—

(40757373) Influenza virus identified in Isolate

160

1.56

1.31

1.2

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

225

1.47

1.30

1.2

1.4

224.70

351.63

nmol/24h

0.29

225

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

270

0.59

1.30

1.0

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.35

1.29

2.5

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

171

1458

1.18

1.28

1.5

1.4

3638.84

2925.12

e6/l

0.16

125

1022

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

622

0.74

1.26

1.4

1.6

874.94

985.72

mu/l

0.55

502

(3008757) Leukocyte morphology finding [Identifier] in Blood

114

939

1.22

1.25

4.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

122

1012

1.21

1.25

1.1

1.59

1.55

g/l

0.59

111

907

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

475

1.31

1.25

2.3

1.9

2.08

2.53

u/field

0.23

328

(3026692) Albumin [Mass/volume] in Peritoneal fluid

269

1.41

1.25

1.3

1.5

12.79

13.38

g/l

0.13

210

(3038071) Oxygen [Partial pressure] in Mixed venous blood

187

1.50

1.23

6.2

7.6

5.64

5.27

kpa

0.36

187

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.00

1.23

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

605

0.74

1.20

1.0

1.1

4.45

3.24

u/ml

0.19

269

(3051339) Copper [Moles/volume] in Blood

2.31

1.18

1.2

20.22

17.09

umol/l

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

306

1.37

1.18

2.1

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

306

1.37

1.18

2.1

2.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2973

30611

0.96

1.18

4.2

16.01

8.57

mg/mmol

6.88

1995

19094

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

676

1.24

1.16

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

1.16

0.0

1.0

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

1.16

0.0

1.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

1.16

0.0

1.1

—

25.25

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

1.16

0.0

1.1

—

31.64

—

(3023420) DNA double strand Ab [Units/volume] in Serum

336

3028

1.11

1.15

2.0

1.7

9.95

6.86

iu/ml

0.60

681

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

317

1.36

1.14

1.1

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

2979

30646

0.96

1.13

3.5

3.4

7.09

7.27

mmol/l

1.50

2548

25423

(3043410) Blood group antigens tested for on Red Blood Cells

258

1.40

1.12

1.6

1.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.33

1.12

3.0

1.9

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

114

0.44

1.12

1.6

2.6

0.58

0.68

ug/l

—

114

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

200

1.45

1.11

1.4

1.2

0.30

0.31

g/l

0.39

159

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

781

1.22

1.10

1.3

1.2

—

41.00

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

639

0.77

1.08

1.6

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

980

0.81

1.06

1.1

25.44

20.93

au/ml

0.14

182

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

703

0.78

1.05

1.6

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

186

1.45

1.05

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

166

1440

1.15

1.05

1.4

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

121

1.57

1.05

1.1

16.34

19.37

u/l

0.48

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

480

1.27

1.04

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

190

1667

1.14

1.03

1.9

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

428

1.29

1.03

2.0

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

428

1.29

1.03

2.0

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

428

1.29

1.03

2.0

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

428

1.29

1.03

2.0

1.8

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

229

1.40

1.03

1.8

1.3

71.18

27.60

g/l

0.46

173

(3025130) Human papilloma virus identified in Specimen

699

0.79

1.01

1.8

1.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

519

0.75

1.01

1.3

1.4

1.50

2.18

u/ml

0.19

310

(3047007) Chlamydophila sp Ab [Presence] in Serum

876

0.81

1.01

1.3

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

369

0.70

1.01

1.5

1.6

20.98

11.36

ug/l

0.31

332

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

369

0.70

1.01

1.3

1.6

69.71

61.32

ug/l

0.36

300

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

308

1.33

0.99

2.2

2.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.84

0.98

1.1

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

414

1.28

0.98

3.3

1.13

1.32

0.52

414

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

145

1254

1.16

0.98

1.7

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

378

0.71

0.97

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

148

1.49

0.97

6.8

7.2

10.27

10.34

0.05

148

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

299

3295

0.90

0.97

1.0

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

627

0.78

0.97

2.0

2.1

3.39

3.47

ug/l

0.03

578

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.00

0.96

0.0

1.1

—

3.34

—

(3004616) Nuclear Ab [Presence] in Serum

989

0.83

0.95

1.2

1.3

—

(21494434) Karyotype in Bone marrow

100

841

1.19

0.95

1.3

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

176

1548

1.14

0.94

2.1

1.6

0.91

0.86

nmol/l

0.55

149

1302

(3014133) Dog dander IgE Ab [Units/volume] in Serum

645

0.79

0.93

1.1

2.82

2.59

u/ml

0.05

319

(3043238) Trisomy 21 risk [Likelihood] in Fetus

292

0.68

0.92

1.4

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.82

0.92

1.0

1.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2245

23131

0.96

0.91

3.1

2.9

354.84

356.26

umol/l

0.24

1958

19994

(3004716) Salmonella sp identified in Stool by Organism specific culture

318

2900

1.10

0.91

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

526

1.24

0.91

1.0

1.1

287.53

287.89

mg/l

0.01

478

(3023487) Leukocytes [#/volume] in Peritoneal fluid

366

1.29

0.90

2.1

1.9

1108.03

4557.10

e6/l

0.70

247

(3020876) Protein [Mass/time] in 24 hour Urine

144

1254

1.15

0.90

2.5

2.3

1.30

1.09

g/24h

0.53

715

(3028433) Virus identified in Specimen by Culture

262

1.34

0.89

1.1

—

(3025577) Chromium [Mass/volume] in Blood

607

0.79

0.88

2.1

1.80

2.14

ug/l

0.56

504

(3042631) Mycobacterium sp identified in Specimen

123

1421

0.86

0.88

2.2

2.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

287

3149

0.91

0.88

1.1

62.00

175.60

titre

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

404

1.26

0.87

1.9

2.3

1133.55

1202.33

u/ml

0.10

399

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

616

0.79

0.86

1.6

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

638

0.80

0.86

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

188

1674

1.13

0.86

1.3

80.00

171.05

titre

—

(40768441) Liver Pathology biopsy report

595

1.21

0.84

1.6

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

424

0.75

0.84

1.2

1.1

19.54

9.11

iu/ml

—

112

(3045414) Leukocytes [Presence] in Urine

891

8479

1.06

0.83

2.2

0.00

0.01

estimate

2.42

151

1592

(3003740) Influenza virus B Ag [Presence] in Specimen

874

0.83

0.82

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

284

0.70

0.81

1.4

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

544

0.79

0.81

1.0

1.1

0.14

0.27

u/ml

0.70

205

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.57

0.81

2.4

1.8

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

338

1.27

0.79

2.0

1.8

64.09

58.57

ug/l

0.13

327

(3021440) Promyelocytes/Leukocytes in Blood

733

7723

0.94

0.79

4.3

4.2

0.14

0.11

0.39

236

2239

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.10

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.79

0.0

1.0

—

410.67

—

(3005033) Fetal Nuchal fold Thickness US

281

0.71

0.78

1.4

1.5

1.42

1.28

0.51

189

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

199

1792

1.11

0.77

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

186

1669

1.12

0.77

1.3

121.54

303.81

titre

2.67

143

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

110

1262

0.87

0.75

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.70

0.75

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

244

0.70

0.75

1.3

15.35

12.29

mm/h

0.40

244

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.64

0.75

1.2

2.52

1.64

umol/24h

0.87

(3002523) Influenza virus A Ag [Presence] in Specimen

875

0.84

0.74

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1666

17187

0.96

0.74

5.1

4.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

324

0.74

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

271

1.29

0.74

1.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

146

1297

1.13

0.73

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

179

1986

0.90

0.72

1.6

1.7

—

37.84

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

112

978

1.15

0.72

1.0

1.1

—

(36660697) Celiac disease serology panel - Serum

530

5618

0.94

0.72

1.2

—

(44806071) Cardiolipin IgM antibody measurement

1.67

0.72

1.0

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

849

1.16

0.71

1.4

1.3

1.35

1.51

nmol/l

0.92

762

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

988

0.86

0.70

1.1

0.79

1.65

u/ml

1.62

558

(40768806) Pleura Pathology biopsy report

139

1234

1.13

0.70

1.4

1.6

—

(40761536) Microorganisms panel - Urine sediment

648

6823

0.95

0.70

6.0

4.3

—

(3000494) Fungus identified in Specimen by Culture

947

9872

0.95

0.70

1.6

1.5

—

(3017181) Myelocytes/Leukocytes in Blood

771

8076

0.95

0.69

4.4

4.2

1.04

0.97

0.30

271

2579

(3045462) Protein/Creatinine [Ratio] in Urine

1.64

0.68

4.0

3.6

17.12

41.37

mg/mmol

—

(3038026) Centromere Ab [Units/volume] in Serum

617

0.83

0.67

1.2

46.62

54.89

u/ml

—

(40765096) Chromosome analysis panel by Banding

284

0.74

0.67

1.2

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.63

0.66

1.3

1.2

—

(4211845) Urine protein measurement

438

1.21

0.66

3.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

202

0.69

0.65

1.4

1.1

—

(3006462) Nitrate [Presence] in Urine

394

1.22

0.65

3.6

3.8

—

(3002179) Metamyelocytes/Leukocytes in Blood

734

7680

0.95

0.65

4.2

4.1

0.82

0.71

0.51

261

2450

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

178

0.67

0.64

1.3

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

185

1681

1.10

0.64

1.5

32.07

31.71

g/l

0.15

164

1520

(3023323) Follitropin [Units/volume] in Serum or Plasma

194

1767

1.10

0.64

1.5

1.4

32.66

31.96

iu/l

0.10

155

1510

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

195

1779

1.10

0.63

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

216

1.30

0.63

1.4

1.1

—

(3049717) Cytology report of Urine Cyto stain

433

4077

1.06

0.63

2.8

2.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

730

0.85

0.62

1.0

1.1

0.61

1.16

u/ml

0.72

380

(3035320) C reactive protein [Mass/volume] in Body fluid

676

0.84

0.62

2.5

2.7

29.37

32.08

mg/l

0.24

499

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

107

944

1.13

0.62

1.2

57.24

64.43

u/l

0.75

824

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.46

0.61

1.6

2.2

2.23

1.38

mmol/l

—

(3000330) Specific gravity of Urine by Test strip

460

4864

0.94

0.61

3.7

3.8

1.02

ratio

2.01

416

4418

(40761539) Cells [Type] in Urine sediment by Light microscopy

233

0.73

0.60

1.1

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.57

0.60

1.8

1.4

—

(3019174) dRVVT (LA screen)

1.57

0.60

1.3

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1078

0.88

0.60

1.5

1.4

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

243

0.74

0.59

1.4

1.2

9.14

15.83

pmol/l

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

0.34

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1075

0.88

0.58

1.5

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

115

0.61

0.57

1.9

1.6

—

(3012441) Differential panel - Pleural fluid

140

1264

1.11

0.57

1.5

—

(3035715) Granulocytes [#/volume] in Blood

136

1505

0.90

0.57

4.3

3.2

4.31

4.34

e9/l

0.04

136

1500

(3021387) Prolactin [Units/volume] in Serum or Plasma

156

1417

1.10

0.57

1.9

1.8

279.24

295.20

mu/l

0.45

143

1309

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1073

0.88

0.56

1.5

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

448

1.18

0.55

1.8

2.2

13.84

16.90

nmol/l

2.58

416

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.62

0.55

1.0

1.8

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.62

0.55

1.0

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1113

0.89

0.55

1.6

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

384

0.81

0.54

1.4

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

612

0.85

0.54

4.8

5.6

24.05

70.39

u/ml

2.36

197

(3025159) Blasts/Leukocytes in Blood

742

7719

0.96

0.54

4.5

4.4

0.50

0.30

0.31

220

2107

(3029396) Erythrocyte agglutination [Presence] in Blood

1.50

0.54

1.9

2.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.41

0.54

1.5

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.41

0.54

1.5

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.41

0.54

1.5

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1047

0.89

0.53

1.2

1.3

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

147

0.68

0.53

1.2

1.1

—

(3025941) Bacteria identified in Stool by Culture

424

4017

1.06

0.53

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7676

77196

0.97

0.53

26.3

18.3

26.25

27.61

mg/l

3.47

7013

65123

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

507

1.16

0.52

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.43

0.52

4.8

6.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

117

1.37

0.52

4.2

2.4

0.50

0.46

u/field

0.08

117

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

230

2138

1.08

0.51

2.5

2.2

140.67

109.03

ug/min

0.37

129

1209

(4015189) Microbial culture of sputum

237

0.76

0.51

2.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.41

0.51

1.0

1.1

0.02

0.03

u/ml

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

153

1670

0.91

0.50

1.1

2.06

9.98

eliau/ml

—

150

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

347

0.81

0.50

1.3

1.5

1.00

1.21

ratio

0.71

210

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

347

0.81

0.50

1.3

1.5

1.13

1.16

ratio

0.03

210

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

347

0.81

0.50

1.3

1.5

0.93

0.96

ratio

0.20

210

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

215

1.26

0.50

1.2

1.3

27.21

30.59

0.18

146

(3021162) Amylase [Enzymatic activity/volume] in Specimen

168

0.71

0.50

4.2

3.1

2340.17

2300.19

u/l

0.01

156

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

547

1.15

0.49

1.6

1.5

9.49

6.67

u/l

0.83

429

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

241

2579

0.93

0.49

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

877

1.12

0.49

1.3

11.01

15.49

u/l

1.44

809

(3027923) C peptide [Moles/volume] in Serum or Plasma

445

1.17

0.49

1.4

1.3

1.15

1.23

nmol/l

0.23

325

(3016750) Collection duration of Urine

492

1.16

0.48

2.7

2.0

499.16

494.65

min

0.13

347

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

289

1.21

0.48

2.0

1.9

1090.00

50242.13

u/ml

—

(3024263) Appearance of Synovial fluid

464

0.84

0.48

1.2

1.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

163

1.29

0.48

1.5

1.9

8.45

9.36

mg/l

0.30

137

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

344

0.81

0.47

1.3

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

528

0.85

0.47

2.9

4.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

438

1.16

0.47

1.5

10.24

6.38

u/l

0.40

371

(3050794) Legionella sp Ab [Presence] in Serum

1.47

0.46

1.0

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

881

1.11

0.46

1.4

1.3

45.80

52.36

u/ml

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

218

1.24

0.46

1.6

0.44

0.38

ug/l

0.17

138

(3021589) Normoblasts [#/volume] in Blood

3556

36019

0.98

0.45

14.1

12.5

0.00

e9/l

0.03

2942

29264

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.59

0.45

5.6

5.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

141

0.71

0.44

1.0

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

112

1.34

0.44

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

821

0.89

0.44

1.1

3.94

3.45

u/ml

0.10

415

(3018333) Ribosomal P Ab [Presence] in Serum

497

1.15

0.44

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

193

1.24

0.43

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

196

0.76

0.42

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.65

0.42

9.3

11.9

0.25

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

162

1502

1.08

0.42

1.5

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

796

0.89

0.42

1.1

0.42

1.05

u/ml

1.71

354

(3023511) Choriogonadotropin [Units/volume] in Urine

332

1.17

0.41

1.3

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.41

0.0

1.8

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

847

0.90

0.41

1.6

1.5

25.88

28.84

0.37

517

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

205

2185

0.94

0.40

1.3

1.2

39.40

43.37

u/ml

—

109

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

2.24

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

183

1958

0.93

0.40

3.8

3.6

28.83

30.09

mg/l

0.18

138

1399

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

114

1.32

0.40

1.3

1.6

—

103.53

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.47

0.40

5.4

8.9

110.00

103.88

g/l

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6400

64406

0.98

0.40

9.3

8.4

83.30

81.97

u/l

1.08

6067

60857

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

216

0.79

0.40

2.8

2.3

6.03

7.73

mmol/l

2.76

137

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

157

1458

1.08

0.40

1.4

4.02

10.96

u/ml

—

(3000060) B lymphocytes [#/volume] in Blood

171

0.76

0.39

3.1

2.2

0.12

1.24

e9/l

—

(4062490) Immunoglobulin typing, IgG

779

1.10

0.38

1.3

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

101

1103

0.91

0.38

1.5

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

301

0.83

0.37

1.5

1.6

—

(3022475) Manganese [Moles/volume] in Blood

1.35

0.37

1.2

1.4

0.11

0.16

umol/l

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

103

944

1.09

0.37

1.1

—

20.10

u/ml

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

245

2585

0.95

0.36

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

245

2584

0.95

0.36

4.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.36

0.36

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

545

1.12

0.35

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3945

39833

0.98

0.35

2.7

2.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.31

0.35

1.9

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

305

2912

1.05

0.34

2.3

2.2

0.00

g/l

0.06

259

2537

(3047189) Immunofixation for 24 hour Urine

489

0.88

0.34

1.8

1.6

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

254

0.83

0.34

2.4

2.1

32.14

29.76

0.29

233

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

853

1.09

0.34

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

786

1.09

0.33

1.3

1.4

3.02

2.88

g/l

0.33

564

(3006504) Eosinophils/Leukocytes in Blood

3906

38668

1.02

0.33

6.9

6.4

2.75

2.85

1.79

3677

35832

(3044007) Cell count panel - Peritoneal fluid

321

1.15

0.33

2.3

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

155

0.77

0.33

1.1

1.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

340

1.15

0.33

1.2

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.30

0.33

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.70

0.33

1.3

1.6

—

(3045142) Bone marrow Pathology biopsy report

100

1082

0.92

0.32

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

105

1133

0.93

0.32

1.5

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

101

1.29

0.31

1.1

1.2

9.43

6.27

mmol/l

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

384

3696

1.04

0.31

2.3

2.2

10.04

10.20

g/l

0.30

329

3229

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.72

0.30

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

175

0.80

0.30

2.9

6.6

8.62

8.40

mmol/l

0.17

175

(3034274) Bile acid [Moles/volume] in Serum --fasting

421

0.88

0.30

1.5

1.7

13.17

12.33

umol/l

0.05

296

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

315

1.14

0.30

1.8

1416.53

18577.31

e6/l

1.77

171

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.27

0.30

1.3

1.1

77.71

95.42

titre

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.31

0.30

1.7

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

534

1.11

0.29

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

534

1.11

0.29

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

837

0.92

0.29

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

213

1.17

0.28

1.8

1.6

12.67

9.78

ug/l

1.38

213

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

123

1152

1.07

0.28

1.9

1.6

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

773

0.92

0.28

1.7

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

1.28

0.28

1.2

64.92

65.97

ug/l

0.04

(3024139) IgG subclass 3 [Mass/volume] in Serum

786

1.08

0.27

1.3

1.4

0.45

0.41

g/l

0.29

559

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

275

2639

1.04

0.27

5.4

3.0

1.77

1.70

mg/l

0.56

252

2339

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

117

0.77

0.27

1.0

1.1

—

(3037756) Immunofixation for Serum or Plasma

238

2277

1.05

0.27

1.5

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

787

1.08

0.27

1.3

1.4

7.40

6.74

g/l

1.04

561

(3050129) First trimester maternal screen panel - Serum or Plasma

406

0.89

0.27

1.5

—

(40762814) Titanium [Mass/volume] in Blood

171

0.82

0.26

2.5

2.3

6.22

3.55

ug/l

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

123

1305

0.94

0.26

1.1

1.2

—

0.83

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

157

1652

0.95

0.25

1.1

2.74

3.79

0.84

153

(3019069) Monocytes/Leukocytes in Blood

3910

38786

1.01

0.25

7.0

6.5

9.19

9.07

1.35

3685

35948

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

559

1.09

0.25

1.2

—

(44813793) Dust mix specific IgE antibody measurement

424

0.90

0.24

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

159

0.82

0.24

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

444

0.90

0.24

6.3

6.8

27.88

210.14

ug/l

1.41

286

(3001729) Color of Synovial fluid

0.73

0.24

1.5

1.6

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

180

1.17

0.23

1.5

1.2

374.09

41.82

mg/l

0.57

132

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

523

1.09

0.23

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.32

0.23

1.8

1.3

—

(3017354) Segmented neutrophils/Leukocytes in Blood

113

1066

1.06

0.23

3.5

3.7

61.42

58.19

0.87

100

901

(3018010) Neutrophils/Leukocytes in Blood

3882

38527

1.01

0.23

6.8

6.3

59.89

58.41

11.28

3725

36464

(3036782) Glucose [Moles/volume] in Pleural fluid

119

1125

1.06

0.23

1.5

1.4

6.23

6.21

mmol/l

0.03

114

1035

(3035880) pH of Pleural fluid

630

1.08

0.23

1.5

1.3

7.42

7.40

0.28

435

(3000034) Microalbumin [Mass/volume] in Urine

814

1.07

0.23

3.1

3.0

17.32

43.00

mg/l

2.15

597

(3012494) Peanut IgE Ab [Units/volume] in Serum

134

1.19

0.22

1.1

0.33

1.40

u/ml

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

295

0.88

0.22

1.5

2.2

25.68

150.00

ug/l

0.71

274

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

157

0.83

0.22

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

210

0.86

0.22

1.4

1.6

56.22

56.89

ug/l

0.03

210

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

487

1.09

0.21

1.7

653.00

330.54

mu/l

0.87

380

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.21

0.0

2.4

—

20.57

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

833

0.94

0.21

1.6

1.5

—

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.12

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

209

0.86

0.21

2.4

2.3

3.94

165.81

ug/l

0.63

209

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.16

0.21

2.2

2.8

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.16

0.21

9.6

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.16

0.21

1.2

1.5

260.00

329.44

umol/24h

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

634

1.07

0.20

1.2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.20

0.0

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4089

40624

1.01

0.20

2.3

2.2

90.87

94.43

pmol/l

5.52

2304

21505

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

180

1730

1.04

0.19

1.3

28.71

36.58

u/l

0.69

158

1483

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

493

4818

1.02

0.19

2.3

2.5

24.28

22.13

au/ml

0.16

421

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

281

2724

1.03

0.19

2.3

0.00

g/l

-0.00

259

2531

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.18

0.19

1.2

1.0

5.00

7.75

u/ml

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

159

1525

1.04

0.19

1.3

1.2

75.51

49.76

u/ml

0.65

147

(4024509) Urine culture

426

4158

1.03

0.19

2.1

2.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

118

1.19

0.19

1.2

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

217

2244

0.97

0.18

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

270

1.11

0.18

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

440

4299

1.02

0.18

2.3

2.1

1.99

0.23

estimate

0.42

126

1214

(3033099) Centromere Ab [Titer] in Serum

175

1.14

0.18

1.2

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

1038

10231

1.02

0.18

1.4

1.3

555.61

494.71

titre

0.46

237

2273

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.21

0.18

1.3

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

518

0.93

0.18

2.0

1.6

108.92

90.87

umol/l

0.24

518

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

312

3035

1.03

0.18

2.3

2.2

0.01

0.04

g/l

2.68

276

2709

(3001964) Herpes simplex virus Ag [Presence] in Specimen

206

0.87

0.18

2.1

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

227

0.88

0.18

1.2

1.8

7.18

4.49

ug/l

0.20

168

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

435

0.92

0.18

1.1

5.19

12.58

nmol/l

—

(3013727) Leukocytes other/Leukocytes in Blood

300

0.90

0.18

3.6

52.11

53.47

0.11

286

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

121

0.83

0.18

1.0

—

(3019225) pH of Specimen

884

8970

0.98

0.17

5.8

4.3

7.36

0.10

684

6331

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

169

1753

0.96

0.17

1.3

1.2

1.55

4.43

u/ml

1.28

118

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

199

2057

0.97

0.17

1.4

1.3

7.96

6.13

u/ml

0.19

303

(4133840) Spirometry

176

1.14

0.17

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

171

1772

0.96

0.17

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

205

1.12

0.17

1.0

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

173

0.87

0.16

4.7

4.9

36.53

57.74

u/l

1.04

166

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

371

0.92

0.16

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

262

2547

1.03

0.16

2.9

3.4

—

0.88

—

(3000012) Reticulocyte production index

158

1638

0.96

0.16

1.9

2.1

0.92

0.90

0.19

108

1123

(3022096) Basophils/Leukocytes in Blood

3891

38689

1.01

0.16

7.0

6.5

0.62

0.66

3.93

3671

35851

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

273

1.10

0.16

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.11

0.16

1.4

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

266

0.90

0.15

1.5

1.7

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

421

0.93

0.15

1.5

1.4

62.88

66.54

0.32

339

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

360

3678

0.98

0.15

2.6

2.3

0.74

0.98

g/l

0.70

302

3085

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

346

3385

1.02

0.14

2.7

3.1

2.89

4.86

ratio

0.84

217

1996

(3027035) Albumin [Mass/time] in 24 hour Urine

0.81

0.14

1.6

1.3

—

539.13

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.81

0.14

1.3

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

177

1715

1.03

0.14

1.8

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

364

3564

1.02

0.14

2.6

2.7

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

246

1.10

0.14

1.2

1.3

122.10

135.59

nmol/l

0.12

173

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

160

0.87

0.14

3.3

2.0

81.37

302.87

pmol/l

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

460

0.93

0.14

2.4

416.14

532.26

e6/l

0.83

372

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

117

1126

1.04

0.14

1.4

1.3

363.93

429.97

u/l

0.46

111

1068

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

340

3330

1.02

0.13

1.6

1.8

39.06

39.30

u/l

0.07

282

2889

(3042010) Triglyceride [Moles/volume] in Pleural fluid

170

1.12

0.13

1.6

1.3

0.89

1.45

mmol/l

0.51

119

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

130

1256

1.04

0.13

1.8

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

180

1.11

0.13

2.2

1.8

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

113

1090

1.04

0.12

1.6

1.5

57.78

62.62

0.74

674

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.18

0.12

1.7

1.8

59.50

46.15

umol/l

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

453

1.06

0.12

1.1

1.2

—

(3022621) pH of Urine by Test strip

668

6762

0.99

0.12

3.2

3.0

6.09

6.06

0.41

488

4794

(3034891) Synovial lining cells/cells in Synovial fluid

435

0.94

0.11

1.7

1.5

4.47

3.37

0.19

(3024980) IgG subclass 4 [Mass/volume] in Serum

130

1261

1.03

0.11

1.6

0.80

0.83

g/l

0.12

115

962

(40765089) Chromosome analysis panel - Blood by G-banded

1.16

0.11

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

133

1294

1.03

0.10

1.3

221.13

214.19

miu/ml

0.06

490

(3010838) Calcium [Moles/time] in 24 hour Urine

145

1413

1.03

0.10

1.7

1.9

4.88

4.76

mmol/24h

0.16

119

1225

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

656

0.96

0.09

1.3

1.2

91.49

106.47

pmol/l

1.61

656

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

164

1.10

0.09

1.4

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

201

2050

0.98

0.09

1.3

2.47

5.97

u/ml

0.89

202

(3002619) Bacteria identified in Specimen by Culture

213

1.08

0.09

1.1

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

311

1.06

0.09

1.2

42.41

39.19

g/l

0.68

154

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

155

1.10

0.09

1.7

1.3

192.27

245.49

u/l

0.09

114

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.11

0.09

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

461

0.95

0.08

1.3

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

532

0.96

0.08

1.3

1.2

20.77

27.15

u/l

0.67

435

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

449

1.05

0.08

1.1

1.2

—

(44786800) Granulocytes/Leukocytes in Body fluid

136

1.10

0.08

1.7

1.3

18.00

24.20

—

100

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.83

0.08

1.2

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

338

0.95

0.08

2.2

1.9

28.13

31.05

0.58

338

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

844

0.97

0.07

1.2

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

445

4402

1.01

0.07

1.2

1.3

60.83

55.24

au/ml

0.21

298

(3004775) Volume in Urine collected for unspecified duration

712

0.97

0.07

2.6

2.1

738.80

650.18

0.77

441

(3000475) Leukocytes [#/volume] in Synovial fluid

230

2334

0.98

0.07

1.6

18978.66

14727.73

e6/l

0.72

167

1629

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

343

1.05

0.07

1.3

226.81

410.75

ug/l

0.36

182

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.83

0.07

3.4

1.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

268

2714

0.99

0.06

1.4

267.88

263.20

ug/g

0.14

160

1657

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

187

1.07

0.06

1.3

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

611

1.03

0.06

3.2

3.9

280.83

203.64

nmol/l

0.30

604

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

568

0.97

0.06

2.4

2.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

148

1.08

0.06

1.3

1.1

600.00

868.57

titre

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

403

3992

1.01

0.06

2.3

2.98

2.93

g/l

0.51

356

3565

(40758558) Short blood count panel - Blood

2510

25162

1.00

0.05

7.1

6.4

—

(3044927) Protein electrophoresis panel - Urine

105

1029

1.02

0.05

1.3

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

435

0.97

0.05

2.2

2.1

155.18

129.42

ug/min

0.10

111

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

426

4291

0.99

0.05

2.2

2.3

4.10

4.18

g/l

1.30

380

3868

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

131

1290

1.02

0.04

1.8

1.9

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

6153

61443

1.00

0.04

32.5

24.0

331.35

331.45

g/l

0.36

6084

61008

(3009214) Lutropin [Units/volume] in Serum or Plasma

147

1489

0.99

0.04

1.5

1.4

12.20

10.56

u/l

0.53

113

1189

(3010144) Erythrocytes [#/volume] in Synovial fluid

884

1.02

0.04

1.4

85940.30

146229.11

e6/l

0.86

592

(3011412) CD3 cells [#/volume] in Blood

724

0.98

0.04

2.4

2.2

955.44

1113.44

e6/l

1.04

647

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

447

4494

0.99

0.03

3.1

3.3

4.29

4.41

pmol/l

1.99

397

3950

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

461

0.98

0.03

2.1

2.7

36.33

37.61

0.22

252

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

238

2361

1.01

0.03

1.6

1.5

0.13

7.24

iu/ml

1.24

506

(3048879) Bone marrow aspiration report

290

1.03

0.03

1.8

1.6

—

2.00

—

(3004809) Band form neutrophils/Leukocytes in Blood

166

1675

0.99

0.03

3.8

3.7

1.72

1.62

0.14

153

1474

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

380

0.97

0.03

1.5

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

309

0.97

0.02

1.5

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

120

1188

1.01

0.02

2.1

2.2

34.00

25.80

mg/l

0.66

434

(21494890) Protein electrophoresis panel - 24 hour Urine

107

1059

1.01

0.02

1.8

2.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

379

3774

1.00

0.02

2.8

3.2

37.97

52.41

mg/l

2.00

323

3159

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

106

1050

1.01

0.01

1.1

22.85

11407.16

iu/ml

0.56

212

(3006270) Folate [Moles/volume] in Blood

771

1.01

0.01

1.2

336.32

342.23

nmol/l

0.09

599

(3034860) Kappa light chains.free [Mass/volume] in Serum

379

3777

1.00

0.01

2.8

3.2

55.54

71.86

mg/l

0.53

323

3165

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

427

4280

1.00

0.01

2.2

2.3

3.74

3.73

g/l

0.04

381

3856

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

208

2089

1.00

0.01

1.6

1.9

12.86

12.24

mg/l

0.35

184

1932

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

100

992

1.01

0.01

3.4

3.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

543

1.01

0.01

1.3

1.2

127.57

91.76

u/l

0.58

454

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

843

1.01

0.00

1.2

1.6

34.11

24.57

u/ml

0.61

180

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

186

0.97

0.00

1.7

1.4

6.11

10.17

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

216

0.97

0.00

1.4

1.2

1.40

1.53

mmol/l

0.40

143

(3002030) Lymphocytes/Leukocytes in Blood

3941

39405

1.00

0.00

6.9

6.4

24.54

26.30

19.42

3745

37001

(3013637) Mi-2 Ab [Presence] in Serum

235

1.02

0.00

1.5

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

235

1.02

0.00

1.5

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

235

1.02

0.00

1.5

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

235

1.02

0.00

1.5

1.0

—

(4212803) Bone marrow aspirate examination

1.03

0.00

1.2

1.0

—

(3014891) Appearance of Pleural fluid

176

1.02

0.00

1.9

1.4

—

(37208534) Antinuclear antibody arbitrary concentration in serum

210

1.00

0.00

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

110

1105

1.00

0.00

1.4

—

(3020491) Glucose [Moles/volume] in Blood

570

1.00

0.00

1.7

2.1

6.98

7.11

mmol/l

0.15

392

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

156

1562

1.00

0.00

2.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

144

0.97

0.00

3.0

2.8

298.60

114.99

au/ml

—

(3017704) Immunofixation for Urine

565

0.99

0.00

1.6

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

200

1.00

0.00

1.6

1.3

1.20

1.18

mmol/l

0.93

200

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

591

1.00

0.00

1.2

1.3

40.98

32.51

u/l

0.97

480

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

429

4293

1.00

0.00

2.2

2.3

7.43

g/l

0.00

383

3865

(3000919) Neutrophils/Leukocytes in Pleural fluid

327

1.01

0.00

1.4

29.13

17.92

1.42

290

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

31.00

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.88

0.00

2.3

6.1

8.83

8.34

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

38.73

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.88

0.00

1.2

3.1

33.00

43.91

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

3763.63

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.85

-0.00

1.0

1.9

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.54

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.98

-0.00

1.7

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

1.4

—

6.40

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.95

-0.00

1.8

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.6

—

0.25

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.95

-0.00

1.5

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.92

-0.00

1.9

1.5

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

0.99

-0.00

3.9

2.3

249.00

465.19

umol/l

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_INTRACRA and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_INTRACRA	2.591 [2.34, 2.87]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.052

During the follow-up period (1.1.1998 — 31.12.2019), 10433 out of 23218 females with I9_INTRACRA died.

Males

Parameter	HR [95% CI]	p-value
I9_INTRACRA	2.552 [2.3, 2.83]	< 0.001
Birth year	0.986 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 11486 out of 25311 males with I9_INTRACRA died.

Mortality risk

Mortality risk for people of age

years, who have I9_INTRACRA.

N-year risk	Females	Males
1	0.217%	0.367%
5	1.26%	2.51%
10	3.11%	7.178%
15	6.083%	12.82%
20	10.536%	20.875%

Relationships between endpoints

↥

Index endpoint: I9_INTRACRA – Nontraumatic intracranial haemmorrhage

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Nontraumatic intracranial haemmorrhage

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints